<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Cell Transplant</journal-id>
      <journal-id journal-id-type="iso-abbrev">Cell Transplant</journal-id>
      <journal-id journal-id-type="publisher-id">CLL</journal-id>
      <journal-id journal-id-type="hwp">spcll</journal-id>
      <journal-title-group>
        <journal-title>Cell Transplantation</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0963-6897</issn>
      <issn pub-type="epub">1555-3892</issn>
      <publisher>
        <publisher-name>SAGE Publications</publisher-name>
        <publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">29852748</article-id>
      <article-id pub-id-type="pmc">6050907</article-id>
      <article-id pub-id-type="doi">10.1177/0963689718759472</article-id>
      <article-id pub-id-type="publisher-id">10.1177_0963689718759472</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Reviews</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Enhancing the Therapeutic Potential of Olfactory Ensheathing Cells in Spinal
Cord Repair Using Neurotrophins</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Wright</surname>
            <given-names>A. A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1-0963689718759472">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Todorovic</surname>
            <given-names>M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1-0963689718759472">1</xref>
          <xref ref-type="aff" rid="aff2-0963689718759472">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tello-Velasquez</surname>
            <given-names>J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1-0963689718759472">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rayfield</surname>
            <given-names>A. J.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1-0963689718759472">1</xref>
          <xref ref-type="aff" rid="aff2-0963689718759472">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>St John</surname>
            <given-names>J. A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1-0963689718759472">1</xref>
          <xref ref-type="aff" rid="aff2-0963689718759472">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ekberg</surname>
            <given-names>J. A.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1-0963689718759472">1</xref>
          <xref ref-type="aff" rid="aff2-0963689718759472">2</xref>
          <xref ref-type="corresp" rid="corresp1-0963689718759472"/>
        </contrib>
      </contrib-group>
      <aff id="aff1-0963689718759472">
<label>1</label>Clem Jones Centre for Neurobiology and Stem Cell Research, Griffith
Institute for Drug Discovery, Griffith University, Nathan, Queensland, Australia</aff>
      <aff id="aff2-0963689718759472">
<label>2</label>Menzies Health Institute Queensland, Griffith University, Southport,
Queensland, Australia</aff>
      <author-notes>
        <corresp id="corresp1-0963689718759472">J. A. Ekberg, Menzies Health Institute Queensland,
Griffith University, Southport, Queensland 4222, Australia. Email:
<email>j.ekberg@griffith.edu.au</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>31</day>
        <month>5</month>
        <year>2018</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>6</month>
        <year>2018</year>
      </pub-date>
      <volume>27</volume>
      <issue>6</issue>
      <fpage>867</fpage>
      <lpage>878</lpage>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>7</month>
          <year>2017</year>
        </date>
        <date date-type="rev-recd">
          <day>01</day>
          <month>1</month>
          <year>2018</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>1</month>
          <year>2018</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; The Author(s) 2018</copyright-statement>
        <copyright-year>2018</copyright-year>
        <copyright-holder content-type="sage">SAGE Publications Inc, unless otherwise noted.
Manuscript content on this site is licensed under Creative Commons
Licenses</copyright-holder>
        <license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This article is distributed under the terms of the Creative Commons Attribution
4.0 License (<ext-link ext-link-type="uri" xlink:href="http://www.creativecommons.org/licenses/by/4.0/">http://www.creativecommons.org/licenses/by/4.0/</ext-link>) which permits any use,
reproduction and distribution of the work without further permission provided the
original work is attributed as specified on the SAGE and Open Access pages (<ext-link ext-link-type="uri" xlink:href="https://us.sagepub.com/en-us/nam/open-access-at-sage">https://us.sagepub.com/en-us/nam/open-access-at-sage</ext-link>).</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Autologous olfactory ensheathing cell (OEC) transplantation is a promising therapy for
spinal cord injury; however, the efficacy varies between trials in both animals and
humans. The main reason for this variability is that the purity and phenotype of the
transplanted cells differs between studies. OECs are susceptible to modulation with
neurotrophic factors, and thus, neurotrophins can be used to manipulate the transplanted
cells into an optimal, consistent phenotype. OEC transplantation can be divided into 3
phases: (1) cell preparation, (2) cell administration, and (3) continuous support to the
transplanted cells in situ. The ideal behaviour of OECs differs between these 3 phases; in
the cell preparation phase, rapid cell expansion is desirable to decrease the time between
damage and transplantation. In the cell administration phase, OEC survival and integration
at the injury site, in particular migration into the glial scar, are the most critical
factors, along with OEC-mediated phagocytosis of cellular debris. Finally, continuous
support needs to be provided to the transplantation site to promote survival of both
transplanted cells and endogenous cells within injury site and to promote long-term
integration of the transplanted cells and angiogenesis. In this review, we define the 3
phases of OEC transplantation into the injured spinal cord and the optimal cell behaviors
required for each phase. Optimising functional outcomes of OEC transplantation can be
achieved by modulation of cell behaviours with neurotrophins. We identify the key growth
factors that exhibit the strongest potential for optimizing the OEC phenotype required for
each phase.</p>
      </abstract>
      <kwd-group>
        <kwd>autologous transplantation</kwd>
        <kwd>glia</kwd>
        <kwd>growth factors</kwd>
        <kwd>cell proliferation</kwd>
        <kwd>neuron</kwd>
      </kwd-group>
      <funding-group>
        <award-group id="award1-0963689718759472">
          <funding-source id="funding1-0963689718759472">
            <institution-wrap>
              <institution>Clem Jones Foundation Grant</institution>
            </institution-wrap>
          </funding-source>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro" id="section1-0963689718759472">
      <title>Introduction</title>
      <p>Spinal cord injury (SCI) can lead to permanent damage for which there is currently no cure.
SCI causes damage to neural tissue, initially due to the direct trauma, which then
progresses due to a series of secondary cellular events causing further damage. After
injury, local inflammation, ischemia, and oxidative stress result in expansive cell death
and damage at the SCI site<sup><xref rid="bibr1-0963689718759472" ref-type="bibr">1</xref></sup>. Subsequently, reactive astrocytes undergo hypertrophy, proliferate, and migrate to
the injury site. They then create a glial scar that impedes growth and reinnervation of
neurons in this area and which acts as a tertiary lesion<sup><xref rid="bibr1-0963689718759472" ref-type="bibr">1</xref><xref rid="bibr2-0963689718759472" ref-type="bibr"/><xref rid="bibr3-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr4-0963689718759472" ref-type="bibr">4</xref></sup>.</p>
      <p>A promising therapy for SCI is the autologous transplantation of olfactory ensheathing
cells (OECs), the glial cells of the primary olfactory nervous system. OECs are taken from
the olfactory epithelium of the nasal cavity, cultured in vitro, and then transplanted into
the damaged SCI site (<xref ref-type="fig" rid="fig1-0963689718759472">Fig. 1</xref>)<sup><xref rid="bibr5-0963689718759472" ref-type="bibr">5</xref></sup>. OECs are present in the primary olfactory nervous system, which comprises the
olfactory nerve and the nerve fiber layer (NFL) of the olfactory bulb (OB). OECs naturally
promote the continuous regeneration of the olfactory nerve that occurs throughout life and
therefore exhibit unique growth-promoting properties. OECs are also capable of migrating
long distances into and interacting with astrocytic glial scar tissue<sup><xref rid="bibr3-0963689718759472" ref-type="bibr">3</xref></sup>, as well as with other cells that may be present in the injury site<sup><xref rid="bibr6-0963689718759472" ref-type="bibr">6</xref></sup>, resulting in a 3-dimensional framework conducive to axonal extension. This
developing treatment has been trialed in rats, dogs, and humans, where it has been shown to
be safe and capable of promoting functional repair in the form of motor and sensory
innervation and allowing for weight bearing movement to varying levels of success<sup><xref rid="bibr7-0963689718759472" ref-type="bibr">7</xref><xref rid="bibr8-0963689718759472" ref-type="bibr"/><xref rid="bibr9-0963689718759472" ref-type="bibr"/><xref rid="bibr10-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr11-0963689718759472" ref-type="bibr">11</xref></sup>. However, in order to create a therapeutic intervention capable of providing
consistent results, autologous OEC transplant therapies must be improved.</p>
      <fig id="fig1-0963689718759472" orientation="portrait" position="float">
        <label>Fig. 1.</label>
        <caption>
          <p>Olfactory ensheathing cells (OECs) and fibroblasts administered to a Schwann cell site
(gray). The mixed cell culture supports and ensheathes the regenerating axons. OEC
phagocytose scar and damaged tissues.</p>
        </caption>
        <graphic xlink:href="10.1177_0963689718759472-fig1"/>
      </fig>
      <p>There are many reasons why outcomes of OEC intervention for spinal cord repair vary from
trial to trial. There are several broadly different methods for inducing SCI in animal
models including hemisection, transection, and contusion injuries, which all have different
effects on the extent of injury. The injuries can all be performed at various cervical and
thoracic levels which again lead to variations in outcomes of the OEC intervention. With
respect to the use of OECs themselves, discrepancies between preclinical trial results can
be broadly attributed to (1) exact anatomical source of the OECs (different subpopulations
of OECs exist with distinct biological properties<sup><xref rid="bibr12-0963689718759472" ref-type="bibr">12</xref></sup>), (2) OEC purity, and (3) OEC survival rates after transplantation.</p>
      <p>As a first step toward improving outcomes and consistency in the use of OECs, the
purification, survival, and behavior of OECs could be optimized for transplantation. One
proposed method of achieving reproducibility is by using neurotrophins, for which OECs
express a multitude of receptors, to promote OEC survival and to drive the cellular
behaviors into those most favorable for transplantation and regeneration.</p>
      <p>A number of studies have highlighted the potential of exploiting OEC characteristics for
therapeutic use within the injured spinal cord. Within the olfactory system environment,
OECs aid and support the extension of axons from olfactory sensory neurons which reside in
the olfactory mucosa in the peripheral nervous system (PNS). The OECs guide the axons up to
the OB within the central nervous system (CNS) where the OECs then contribute to the sorting
of olfactory axons to their appropriate targets within the olfactory bulbar glomeruli as
dictated by the olfactory receptor profile of the neurons<sup><xref rid="bibr13-0963689718759472" ref-type="bibr">13</xref><xref rid="bibr14-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr15-0963689718759472" ref-type="bibr">15</xref></sup>. Furthermore, OECs can infiltrate scar tissue and astrocytic environments. Due to
their unique heparin profile<sup><xref rid="bibr3-0963689718759472" ref-type="bibr">3</xref></sup>, OECs can interact and intermingle with astrocytes in ways that Schwann cells (SCs)
and oligodendrocytes cannot. This feature may allow OECs to disperse throughout the glial
scar which is formed following SCI, providing a scaffold for neuronal growth through an
otherwise neurotoxic environment. Furthermore, OECs have been shown to possess phagocytic capabilities<sup><xref rid="bibr16-0963689718759472" ref-type="bibr">16</xref>,<xref rid="bibr17-0963689718759472" ref-type="bibr">17</xref></sup>. In the olfactory system, this capability allows for the removal of axonal debris
during early development as well as a mechanism for bacterial removal<sup><xref rid="bibr18-0963689718759472" ref-type="bibr">18</xref></sup>; however, within the injured spinal cord, this may allow for removal of cytotoxic
debris that can inhibit the regeneration of neurons. Further studies into OEC properties
have demonstrated facilitation of axon extension<sup><xref rid="bibr19-0963689718759472" ref-type="bibr">19</xref></sup>, secretion of neuroprotective and stimulatory proteins which can enhance the
properties of neurons and other glia<sup><xref rid="bibr20-0963689718759472" ref-type="bibr">20</xref>,<xref rid="bibr21-0963689718759472" ref-type="bibr">21</xref></sup>, and an ability to integrate and support other cell types<sup><xref rid="bibr22-0963689718759472" ref-type="bibr">22</xref></sup>. Within the context of SCI, these cellular behaviors may prove ideal for supporting
and guiding axonal regeneration to reform severed connections. However, what is now needed
is to further optimize these features to enhance the therapeutic potential of OECs and to
achieve consistency between treatments.</p>
      <p>OECs express a variety of neurotrophin receptors including p75 neurotrophin receptor
(P75NTR); tropomyosin receptor kinase A (TrkA), tropomyosin receptor kinase B (TrkB), and
tropomyosin receptor kinase C (TrkC); 2 types of glial-derived neurotrophic factor (GDNF)
family receptors: GDNF receptor alpha 1 (GFR&#x3B1;-1) and the tyrosine kinase receptor RET; and
the fibroblast growth factor (FGF) receptor 1 (FGFR1; <xref rid="table1-0963689718759472" ref-type="table">Table 1</xref>). Neurotrophins acting on these receptors
have been shown to promote favorable OEC behaviors, in particular cell migration and
cell&#x2013;cell interactions<sup><xref rid="bibr19-0963689718759472" ref-type="bibr">19</xref>,<xref rid="bibr37-0963689718759472" ref-type="bibr">37</xref></sup>, as well as influence the survival and viability of neurons and their axonal extensions<sup><xref rid="bibr38-0963689718759472" ref-type="bibr">38</xref>,<xref rid="bibr39-0963689718759472" ref-type="bibr">39</xref></sup>. Additionally, many of these receptors are also present on neurons, oligodendrocytes,
SCs, astrocytes, and other supporting cells found throughout the nervous system. Using
neurotrophins as therapeutic agents may not only be utilized to target transplanted OECs but
also to aid in the regeneration of neurons at the injury site&#x2014;a process involving modulation
of these other cell types.</p>
      <table-wrap id="table1-0963689718759472" orientation="portrait" position="float">
        <label>Table 1.</label>
        <caption>
          <p>Receptor Expression and Corresponding Cell Types.</p>
        </caption>
        <alternatives>
          <graphic xlink:href="10.1177_0963689718759472-table1"/>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Neurotrophin Receptor</th>
                <th rowspan="1" colspan="1">Cell Type</th>
                <th rowspan="1" colspan="1">Neurotrophin</th>
                <th rowspan="1" colspan="1">References</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">TrkA</td>
                <td rowspan="1" colspan="1">Neurons</td>
                <td rowspan="1" colspan="1">NGF and NT-3</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr23-0963689718759472" ref-type="bibr">23</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">TrkB</td>
                <td rowspan="1" colspan="1">Neurons and OECs</td>
                <td rowspan="1" colspan="1">BDNF, NT-3, and NT-4</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr23-0963689718759472" ref-type="bibr">23</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">TrkC</td>
                <td rowspan="1" colspan="1">SCs, neurons, and OECs</td>
                <td rowspan="1" colspan="1">NT-3</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr23-0963689718759472" ref-type="bibr">23</xref>,<xref rid="bibr24-0963689718759472" ref-type="bibr">24</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">P75NTR</td>
                <td rowspan="1" colspan="1">SCs, OECs, and dorsal root ganglion neurons</td>
                <td rowspan="1" colspan="1">BDNF and NGF</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr24-0963689718759472" ref-type="bibr">24</xref><xref rid="bibr25-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr26-0963689718759472" ref-type="bibr">26</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">GFR&#x3B1;-1</td>
                <td rowspan="1" colspan="1">SCs, OECs, and neurons</td>
                <td rowspan="1" colspan="1">GDNF</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr27-0963689718759472" ref-type="bibr">27</xref><xref rid="bibr28-0963689718759472" ref-type="bibr"/><xref rid="bibr29-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr30-0963689718759472" ref-type="bibr">30</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">RET</td>
                <td rowspan="1" colspan="1">OECs and neurons</td>
                <td rowspan="1" colspan="1">GDNF</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr29-0963689718759472" ref-type="bibr">29</xref>,<xref rid="bibr30-0963689718759472" ref-type="bibr">30</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">VEGFR2</td>
                <td rowspan="1" colspan="1">Blood vessel endothelial cells</td>
                <td rowspan="1" colspan="1">VEGF</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr31-0963689718759472" ref-type="bibr">31</xref>,<xref rid="bibr32-0963689718759472" ref-type="bibr">32</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">EGFR</td>
                <td rowspan="1" colspan="1">Activated astrocytes and oligodendrocytes</td>
                <td rowspan="1" colspan="1">EGF</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr33-0963689718759472" ref-type="bibr">33</xref>,<xref rid="bibr34-0963689718759472" ref-type="bibr">34</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">FGFR1</td>
                <td rowspan="1" colspan="1">Astrocytes, OEC, SCs, and fibroblasts</td>
                <td rowspan="1" colspan="1">FGF2</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr3-0963689718759472" ref-type="bibr">3</xref>,<xref rid="bibr35-0963689718759472" ref-type="bibr">35</xref></sup>
</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">PDGFR&#x3B1;</td>
                <td rowspan="1" colspan="1">Fibroblasts, oligodendrocytes, and astrocytes</td>
                <td rowspan="1" colspan="1">PDGF-AA and PDGF-BB</td>
                <td rowspan="1" colspan="1">
<sup><xref rid="bibr36-0963689718759472" ref-type="bibr">36</xref></sup>
</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
        <table-wrap-foot>
          <fn id="table-fn1-0963689718759472">
            <p>Abbreviations: TrkA, tropomyosin receptor kinase A; TrkB, tropomyosin receptor kinase
B; TrkC, tropomyosin receptor kinase C; P75NTR, p75 neurotrophin receptor; GFR&#x3B1;-1,
GDNF receptor alpha 1; RET, receptor tyrosine kinase; PDGF, platelet-derived growth
factor; PDGFR, PDGF receptor; OEC, olfactory ensheathing cell; SCs, Schwann cells;
NGF, nerve growth factor; BDNF, brain-derived neurotrophic factor; NT, neurotrophin;
GDNF, glial-derived neurotrophic factor; VEGF, vascular endothelial growth factor;
VEGFR2, VEGF receptor 2; EGF, epidermal growth factor; FGF2, fibroblast growth factor
2; PDGF-AA, dual alpha-subunit of PDGF; PDGF-BB, dual &#x3B2;-subunit of PDGF.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="section2-0963689718759472">
      <title>Using Neurotrophins as Therapeutic Agents in SCI Repair</title>
      <p>Using OECs to repair the injured spinal cord involves (1) harvesting and expansion of OECs,
then (2) transplantation followed by (3) integration and survival of the cells at the site
of injury<sup><xref rid="bibr40-0963689718759472" ref-type="bibr">40</xref></sup>. All 3 phases must be successful to achieve a significant functional outcome. Through
the use of neurotrophins, it may be possible to enhance the outcomes of all 3 of these
phases, with a combination of neurotrophins being tailored to the requirements of each
phase. Thus, neurotrophins can (1) be applied to OECs following biopsy to promote
proliferation in preparation for transplantation, (2) be coadministered along with OECs to
support the cells during transplantation, and (3) act in the longer term at the SCI site,
leading to greater integration and survival of OECs following transplantation. Within the
final phase, the neurotrophins may also exert important effects on other cell types, such as
cell&#x2013;cell interactions or remyelination, as well as on the extracellular environment, for
example, altered growth factor profile of the extracellular matrix.</p>
    </sec>
    <sec id="section3-0963689718759472">
      <title>OEC Proliferation and Preparation Prior to Transplantation into the Injured Spinal
Cord</title>
      <p>Key factors accounting for the variable outcomes of OEC transplantation are the quality,
purity, and source of the cells&#x2014;all of which may influence the phenotype and behavior of the
OECs to be transplanted. A high-quality population of OECs must be prepared prior to
application and should consist of cells that are (1) highly proliferative, to achieve an
appropriate number of cells for transplantation in a prompt time period, allowing the
transplantation to occur sooner, and (2) resilient to surviving the transplantation
process&#x2014;thus increasing the number of viable cells transplanted. It may be possible to
manipulate this preparatory period using neurotrophins to adjust OEC phenotype, induce
purification, and improve viability of OEC populations.</p>
      <sec id="section4-0963689718759472">
        <title>OEC Source and Phenotype</title>
        <p>OECs are present throughout the entire olfactory nervous system from inside the nasal
cavity to the OB<sup><xref rid="bibr14-0963689718759472" ref-type="bibr">14</xref></sup>. OECs exhibit distinct roles based on their location and thus different phenotypes.
OECs within the lamina propria (LP-OECs) of the olfactory mucosa are located along the
length of the olfactory nerve and guide axons from olfactory sensory neurons as they
project toward the OB. The OECs create channels through which the axons extend, and the
channels formed by OECs are in turn encompassed by fibroblasts that act as a
perineurium-like structure<sup><xref rid="bibr41-0963689718759472" ref-type="bibr">41</xref></sup>. In contrast to SCs (the main glia of the PNS), OECs do not myelinate individual
axons but rather ensheathe small fascicles (bundles) of unmyelinated axons in a process
similar to the early stages of nervous system development<sup><xref rid="bibr42-0963689718759472" ref-type="bibr">42</xref></sup>. OEC channels guide the immature olfactory sensory neuron axons through the
cribriform plate into the NFL of the OB in the CNS. OECs within the NFL of the OB-OECs
have characteristics different from that of the LP-OECs as they aid the sorting and
directing of axons toward their appropriate glomerulus according to their respective
odorant receptor (<xref ref-type="fig" rid="fig2-0963689718759472">Fig. 2</xref>), for
which there are 400 functionally distinct genes in humans<sup><xref rid="bibr13-0963689718759472" ref-type="bibr">13</xref>,<xref rid="bibr14-0963689718759472" ref-type="bibr">14</xref></sup>.</p>
        <fig id="fig2-0963689718759472" orientation="portrait" position="float">
          <label>Fig. 2.</label>
          <caption>
            <p>Location of olfactory ensheathing cells (OECs) within the olfactory system. Olfactory
neurons extend axons from the nasal cavity through the cribriform plate and make
connections within the glomeruli with mitral cells. OECs ensheathe the olfactory
axons, aiding their growth and directing them to form their connections.</p>
          </caption>
          <graphic xlink:href="10.1177_0963689718759472-fig2"/>
        </fig>
        <p>Both LP-OECs and OB-OECs have been used for SCI transplantation studies of animals and
humans. A recent study showed that transplanting OB-OECs from the OB produced functional
recovery in a 38-y-old SCI patient who had a spinal cord transection leaving an 8-mm gap
in the spinal cord at thoracic vertebral level nine<sup><xref rid="bibr10-0963689718759472" ref-type="bibr">10</xref></sup>. While the transplantation resulted in improved motor and sensory functional
outcomes in this case, harvesting cells from the OB can cause severe side effects, such as
hyposmia and depression<sup><xref rid="bibr43-0963689718759472" ref-type="bibr">43</xref></sup>. For this reason, it is favorable to use a less invasive biopsy procedure to obtain
LP-OECs from the olfactory mucosa<sup><xref rid="bibr5-0963689718759472" ref-type="bibr">5</xref>,<xref rid="bibr44-0963689718759472" ref-type="bibr">44</xref></sup>. It is, however, possible that OECs from distinct anatomical sources may exhibit
differential ability to promote axonal regeneration. One review systematically compared
multimetric outcomes (electrophysiological, behavioral, and magnetic resonance imaging
results) between LP-OECs and OB-OECs and found that the 2 cell types induced comparable
outcomes; however, the advantage of OB-OECs was that they do not need the same extent of
purification as peripheral OECs<sup><xref rid="bibr45-0963689718759472" ref-type="bibr">45</xref></sup>. Thus, both peripheral and bulb OECs exhibit advantages and disadvantages. If
future studies determine that OB-OECs indeed do lead to better outcomes than LP-OECs, it
is also possible that growth factor modulation can change the phenotype of LP-OECs toward
a type with similar features to OB-OECs. Therefore, a thorough characterization of how
growth factors modulate OECs is highly warranted in the field.</p>
      </sec>
      <sec id="section5-0963689718759472">
        <title>Cell Purity</title>
        <p>Another variability between studies is the purity of the OECs. As the common biopsy
region also contains fibroblasts and other contaminant cells, there have been studies
focusing on purification methods for OECs<sup><xref rid="bibr46-0963689718759472" ref-type="bibr">46</xref></sup>. Currently, the importance of OEC population purity for transplantation is debated,
as other cell types from the olfactory epithelium may also exert important beneficial
effects on neural regeneration<sup><xref rid="bibr7-0963689718759472" ref-type="bibr">7</xref>,<xref rid="bibr10-0963689718759472" ref-type="bibr">10</xref>,<xref rid="bibr47-0963689718759472" ref-type="bibr">47</xref>,<xref rid="bibr48-0963689718759472" ref-type="bibr">48</xref></sup>. In the previously described case showing functional improvement of a patient with
thoracic level 9 SCI, OECs comprised only 16% of the cells transplanted with the majority
of cells likely being fibroblasts<sup><xref rid="bibr10-0963689718759472" ref-type="bibr">10</xref></sup>. Additionally, pure OECs have been suggested to be less resilient to the harsh
environment of the SCI site<sup><xref rid="bibr10-0963689718759472" ref-type="bibr">10</xref></sup>. However, regardless of whether a homogenous or heterogeneous OEC population is
more beneficial, purifying these populations is essential so that the optimal ratio
between OECs and other cell types, in particular fibroblasts, can be determined.</p>
        <p>The aforementioned issues may be addressed using neurotrophins by favoring OEC purity
through selective promotion of proliferation and by improving resilience of cells through
neuroprotective effects. Neurotrophin-3 (NT-3) is currently used as a purification agent
and has been shown to stimulate proliferation of OECs over other cells (<xref ref-type="fig" rid="fig3-0963689718759472">Fig. 3</xref>). This method has been
demonstrated to achieve a 90% to 95% pure population of OECs by passage 5<sup><xref rid="bibr46-0963689718759472" ref-type="bibr">46</xref></sup>. Furthermore, human OECs cultured in the presence of NT-3, demonstrated a 25%
increase in cells that fit OEC receptor expression and appearance, and a 30% decrease in
cells that did not<sup><xref rid="bibr46-0963689718759472" ref-type="bibr">46</xref></sup>.</p>
        <fig id="fig3-0963689718759472" orientation="portrait" position="float">
          <label>Fig. 3.</label>
          <caption>
            <p>Primary olfactory ensheathing cells (OECs) are cultured from an explant tissue.
Following the initial outgrowth, the explant is removed and the cells are passaged.
Neurotrophin 3 may be used as a purification agent to facilitate expansion of OECs
rather than fibroblasts<sup><xref rid="bibr8-0963689718759472" ref-type="bibr">8</xref></sup>.</p>
          </caption>
          <graphic xlink:href="10.1177_0963689718759472-fig3"/>
        </fig>
      </sec>
      <sec id="section6-0963689718759472">
        <title>Cell Viability</title>
        <p>An important point to consider is whether supporting the cells with neurotrophins prior
to transplantation can improve the long-term quality of the OECs after transplantation.
While OECs may thrive in vitro, following transplantation, around 99% of the transplanted
cells die<sup><xref rid="bibr49-0963689718759472" ref-type="bibr">49</xref></sup>. This issue may also be addressed by manipulating the cells with neurotrophins in
culture to improve cellular resilience to pathological and noxious environments following
transplantation. To date, relatively little is known regarding which neurotrophins enhance
the viability of OECs. NT-3 is likely to aid in this process as it promotes proliferation
and survival of OECs (discussed earlier). NT-3 also exerts beneficial effects on other
neural cells; for example, it has been shown to combat apoptosis and prolong survival of
chronically injured neurons when applied locally to an SCI site together with OECs<sup><xref rid="bibr50-0963689718759472" ref-type="bibr">50</xref></sup>. Additionally, OECs transfected to express higher levels of NT-3 have been shown to
induce a much greater recovery in an injured rat model compared to NT-3 or OECs alone<sup><xref rid="bibr51-0963689718759472" ref-type="bibr">51</xref></sup>. While it is possible that NT-3 has a direct effect on OEC viability, this has not
been proven experimentally to date.</p>
        <p>In addition to NT-3 and GDNF, OECs secrete nerve growth factor (NGF) and brain-derived
neurotrophic factor (BDNF). LP-OECs and OB-OECs from the outer NFL express the NGF
receptor P75, along with TrkA, TrkB, and TrkC which are receptors for NGF, BDNF, and NT-3, respectively<sup><xref rid="bibr52-0963689718759472" ref-type="bibr">52</xref><xref rid="bibr53-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr54-0963689718759472" ref-type="bibr">54</xref></sup>. Thus, while NGF may exert a regulatory role on OECs, the OEC features and
behaviors regulated by NGF remain unknown. NGF is known to exert a neuroprotective role on
other nervous system cells, for example, inhibiting apoptosis in a neural cell line (PC12
cells) via binding to the TrkA receptor<sup><xref rid="bibr55-0963689718759472" ref-type="bibr">55</xref></sup>. Conversely, while NGF has been demonstrated to be neuroprotective, it has also
been shown to play a role in the stimulation of apoptosis in other cell types. This
variable effect is due to the differential binding affinities of the Trk receptors and
P75NTR. For example, NGF, BDNF, and NT-3 bind to TrkA, TrkB, and TrkC, respectively, but
also have low-affinity binding with P75NTR. P75NTR has been linked with effects of cell
survival, apoptosis, proliferation, differentiation, regeneration, axonal extension, and
neuronal outgrowth depending on the cells that express them<sup><xref rid="bibr56-0963689718759472" ref-type="bibr">56</xref><xref rid="bibr57-0963689718759472" ref-type="bibr"/><xref rid="bibr58-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr59-0963689718759472" ref-type="bibr">59</xref></sup>. The range of pathways and cobinding involving these receptors can lead to opposing
effects depending on several factors including cell health, ceramide presence,
neurotrophin concentration, and others<sup><xref rid="bibr4-0963689718759472" ref-type="bibr">4</xref>,<xref rid="bibr59-0963689718759472" ref-type="bibr">59</xref>,<xref rid="bibr60-0963689718759472" ref-type="bibr">60</xref></sup>. To date, the effects of growth factors on OECs, in particular on different OEC
populations, remain to be determined. In summary, NT-3, NGF, GDNF, and BDNF may all play
important regulatory roles relating to OEC viability, but this remains to be
systematically determined.</p>
      </sec>
    </sec>
    <sec id="section7-0963689718759472">
      <title>Coadministration of Neurotrophins during OEC Transplantation</title>
      <p>Although cell quality may be improved by pretreatment with neurotrophins, neurotrophic
factors can also be coadministered during transplantation. This can address the issue of
cell death primarily in 2 ways: (1) by stimulating protective pathways preventing cell death
and (2) by stimulating cell proliferation to promote cell replenishment. Furthermore,
neurotrophin stimulation can promote cell&#x2013;cell interactions, resulting in better cell
survival, contact-mediated migration, and integration<sup><xref rid="bibr6-0963689718759472" ref-type="bibr">6</xref></sup>. The successful use of neurotrophins during the transplantation process should aid in
the increase of the cellular resilience, decrease in the cytotoxic environment, and promote
the successful integration of the transplanted cells.</p>
      <sec id="section8-0963689718759472">
        <title>Neuroprotection during Transplantation</title>
        <p>NGF would appear to be a possible candidate for coadministration with OECs. NGF exhibits
protective effects against TrkA-positive cells such as neurons and may be able to further
support neurons in addition to the effects of OECs<sup><xref rid="bibr55-0963689718759472" ref-type="bibr">55</xref></sup>. However, NGF binding to P75NTR during stress stimulates a stress-related pathway.
In this pathway, ceramide, (a lipid molecule found in the cell membrane), phosphorylates
the stress-activated protein kinase (SAPK), the downstream effect of which is cell death.
Therefore, NT-3 may be a more appropriate candidate as it has demonstrated clear effects
on OECs that are likely to be beneficial in vivo<sup><xref rid="bibr46-0963689718759472" ref-type="bibr">46</xref>,<xref rid="bibr55-0963689718759472" ref-type="bibr">55</xref></sup>.</p>
      </sec>
      <sec id="section9-0963689718759472">
        <title>Phagocytosis during Transplantation</title>
        <p>As mentioned previously, following cell transplantation, most cells will not survive<sup><xref rid="bibr49-0963689718759472" ref-type="bibr">49</xref></sup>. In addition to being counterproductive to transplantation efforts, this cell death
leaves a large swath of toxic cellular debris within the transplantation site, which can
be detrimental to neuron growth. One aspect of glial cell biology that has only recently
been characterized is glial-mediated phagocytosis. Phagocytosis of axonal debris is a
crucial aspect of the continuous regeneration that occurs in the olfactory nerve, and it
is a property of OECs that may be particularly important in spinal cord regeneration<sup><xref rid="bibr61-0963689718759472" ref-type="bibr">61</xref></sup>. OECs are highly phagocytic<sup><xref rid="bibr61-0963689718759472" ref-type="bibr">61</xref></sup>, and so by engulfing this cellular debris, OECs create an environment more
favorable for axonal regeneration. Increasing the phagocytic capability of OECs may
therefore be highly beneficial for functional outcomes following transplantation, and thus
identifying neurotrophins that enhance this effect is highly warranted.</p>
        <p>To date, the effects of neurotrophins on phagocytosis are largely unknown. Natural
products have been utilized to increase phagocytic potential of OECs, which is highly
correlated with increased activity of lamellipodial (membranous) extensions<sup><xref rid="bibr62-0963689718759472" ref-type="bibr">62</xref></sup>. While the direct effect on phagocytosis by growth factors is not yet
characterized, neurotrophins capable of inducing lamellipodia, such as GDNF<sup><xref rid="bibr6-0963689718759472" ref-type="bibr">6</xref></sup>, may also enhance the phagocytic potential of OECs. Additionally, NGF and BDNF play
a neuroprotective role and can cause behavioral changes in OECs via the Mitogen-activated
protein kinase kinase / extracellular signal-related kinase (Mek/Erk) pathways<sup><xref rid="bibr63-0963689718759472" ref-type="bibr">63</xref></sup> which also regulate phagocytic activity<sup><xref rid="bibr62-0963689718759472" ref-type="bibr">62</xref></sup>. While the possibility of these neurotrophins influencing the phagocytic activity
of OECs has not been investigated, they present a possible starting point for research
into using neurotrophins to manipulate OECs into a state that is conducive for consistent
functional SCI repair.</p>
      </sec>
      <sec id="section10-0963689718759472">
        <title>Modulation of the Inflammatory Response within the SCI Site by Transplanted
OECs</title>
        <p>In addition to phagocytosing debris, which may aid in clearing the injury site, OECs may
modulate the endogenous inflammatory response (mainly mediated by astrocytes and
microglia) in a manner favoring neural regeneration. Microarray analyses have shown that
OECs express a large number of cytokines involved in the recruitment of immune cells<sup><xref rid="bibr64-0963689718759472" ref-type="bibr">64</xref><xref rid="bibr65-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr66-0963689718759472" ref-type="bibr">66</xref></sup>, suggesting that OECs do indeed interact with immune cells and regulate
inflammatory responses. After injury (bulbectomy), OECs upregulate expression of
interleukin 6 and its receptor, which may play a key role both in mediated axonal
regeneration and in modulation of inflammation<sup><xref rid="bibr67-0963689718759472" ref-type="bibr">67</xref>,<xref rid="bibr68-0963689718759472" ref-type="bibr">68</xref></sup>.</p>
        <p>The presence of OECs does not induce stress responses in astrocytes<sup><xref rid="bibr69-0963689718759472" ref-type="bibr">69</xref></sup>. In fact, the presence of OECs reduced the expression of glial fibrillary acidic
protein (GFAP; a marker of reactive astrocytes) in an in vitro model of astrogliosis<sup><xref rid="bibr70-0963689718759472" ref-type="bibr">70</xref></sup>. One study compared the expression of proinflammatory cytokines and markers of
astrocyte reactivity between OEC-transplanted and mock-transplanted rats with SCI.
OEC-transplanted rats exhibited an earlier peak in the immunoreactivity of inducible
nitric oxide synthase, GFAP (a marker of reactive astrocytes), and tomato lectin (a marker
of microglia) than mock-transplanted animals, suggesting that one of the mechanisms by
which OECs are neuroprotective is by causing an earlier, shorter immune response by
astrocytes and microglia<sup><xref rid="bibr71-0963689718759472" ref-type="bibr">71</xref></sup>. OECs have also been shown to attenuate stimulated nuclear factor &#x3BA;&#x3B2; translocation
in astrocytes, a key response involved in astrocyte activation/inflammation, along with
expression of the proinflammatory cytokine granulocyte macrophage colony-stimulating
factor. It is thought that insulin-like growth factor-1 secreted by OECs contributes to
this modulation of astrocyte activation<sup><xref rid="bibr72-0963689718759472" ref-type="bibr">72</xref></sup>.</p>
        <p>Thus far, the mechanisms by which OECs may modulate the inflammatory state and activation
of astrocytes and microglia after transplantation into the injured cord remain a largely
unexplored field. In particular, it remains unknown how neurotrophins regulate
OEC-mediated modulation of inflammation. The astrocyte scar is detrimental for axonal
regeneration, and thus a characterization of how OECs modulate inflammatory cells within
the injury site may lead to significantly enhanced therapeutic potential of transplanted
OECs.</p>
      </sec>
      <sec id="section11-0963689718759472">
        <title>Cell Transplant Integration</title>
        <p>A successful therapeutic outcome following OEC transplantation into an SCI site is highly
dependent on the ability of the transplanted cells to integrate into the transplantation
site. OECs have shown to rely upon cell&#x2013;cell contact for growth stimulation, and so a
neurotrophin that encourages this action would be beneficial for integration of the
transplanted cells within the SCI site. GDNF is an interesting candidate with already
proven beneficial effects on OECs, such as membrane protrusions (so-called lamellipodial
waves) that promote cell&#x2013;cell contacts, resulting in contact-mediated migration<sup><xref rid="bibr6-0963689718759472" ref-type="bibr">6</xref>,<xref rid="bibr8-0963689718759472" ref-type="bibr">8</xref>,<xref rid="bibr39-0963689718759472" ref-type="bibr">39</xref></sup>. These features may allow the transplanted OECs to penetrate into the SCI site and
integrate following transplantation<sup><xref rid="bibr6-0963689718759472" ref-type="bibr">6</xref>,<xref rid="bibr8-0963689718759472" ref-type="bibr">8</xref></sup>. Additionally, the total membrane protrusion surface area seen in OECs has been
shown to increase up to 13 times following GDNF administration, resulting in a
contact-mediated migration and the formation of a cellular network<sup><xref rid="bibr6-0963689718759472" ref-type="bibr">6</xref></sup>. Similarly, at lower concentrations (10 to 20 ng/mL), OECs have been shown to
decrease intercellular distance and form tight chains of adherent cells which act as a
growth substrate for neurons to follow during regeneration<sup><xref rid="bibr73-0963689718759472" ref-type="bibr">73</xref></sup>. As OECs are capable of intermingling with reactive astrocytes found in the
astrocytic scar, OEC chain formations may allow axonal extension through this otherwise
impenetrable environment<sup><xref rid="bibr3-0963689718759472" ref-type="bibr">3</xref>,<xref rid="bibr21-0963689718759472" ref-type="bibr">21</xref></sup>. Furthermore, GDNF is strongly implicated in the survival of dopaminergic and
autonomic neurons, where it dramatically increases neurite differentiation and outgrowth
at a half-maximal effect concentration of 1.2 pM<sup><xref rid="bibr38-0963689718759472" ref-type="bibr">38</xref></sup>. Thus, GDNF is unlikely to have detrimental effects on cells endogenous to the
injury site.</p>
        <p>BDNF is a neurotrophin secreted from OECs, dorsal root ganglion neurons, and myocytes and
is a promising neurotrophic agent for SCI therapies when used alone or in conjunction with
OEC transplants<sup><xref rid="bibr25-0963689718759472" ref-type="bibr">25</xref>,<xref rid="bibr74-0963689718759472" ref-type="bibr">74</xref>,<xref rid="bibr75-0963689718759472" ref-type="bibr">75</xref></sup>. BDNF has been implicated in neuroprotective and morphological changes<sup><xref rid="bibr76-0963689718759472" ref-type="bibr">76</xref></sup>. For example, BDNF has been shown to stimulate thicker cellular processes of
retinal ganglion cells (RGCs) and has greatly increased RGC migration in scratch assays<sup><xref rid="bibr77-0963689718759472" ref-type="bibr">77</xref></sup>. Another study showed that following transplantation of OECs into a transected
optic nerve, the RGC life span was increased, correlating with the concentration of BDNF
secreted from OECs. This suggests that the key to increased RGC survival was both the
presence of OECs and OEC-secreted BDNF. In the PNS, BDNF secretion can promote migration
and myelination by SCs. Signaling through GTPase Ras-related C3 botulinum toxin substrate
1 (Rac1) influence myelination by SCs<sup><xref rid="bibr25-0963689718759472" ref-type="bibr">25</xref>,<xref rid="bibr78-0963689718759472" ref-type="bibr">78</xref></sup>. Increasing levels of active Rac1 are caused by upregulated 3&#x2019;,5&#x2019;-cyclic adenosine
monophosphate (cAMP) production due to BDNF stimulation. These high levels of Rac1 have
been shown to produce radial lamellae in SCs&#x2014;a phenotype that is highly conducive to
myelination and sorting of axons<sup><xref rid="bibr79-0963689718759472" ref-type="bibr">79</xref></sup>. By increasing cAMP production further through the addition of forskolin (which
stimulates cAMP production), it may be possible to amplify the BDNF-induced myelination;
however, further investigation into whether these same myelinating effects can be seen in
OECs is still required<sup><xref rid="bibr78-0963689718759472" ref-type="bibr">78</xref>,<xref rid="bibr80-0963689718759472" ref-type="bibr">80</xref></sup>.</p>
      </sec>
    </sec>
    <sec id="section12-0963689718759472">
      <title>Effects of Neurotrophins at the SCI Site Following Transplantation</title>
      <p>A continued regimen of neurotrophins, applied postsurgery, could be used to further support
the SCI patient during their recovery. In addition to being used during OEC expansion in
vitro and as a supportive compound during transplantation, neurotrophins could be used to
support the greater injury site area. Neurons, astrocytes, oligodendrocytes, and surrounding
cells all express a variety of neurotrophic receptors which may be used to manipulate the
SCI site to promote neurogenesis, transplant integration, and angiogenesis.</p>
      <sec id="section13-0963689718759472">
        <title>Neurons within the SCI Site</title>
        <p>As the primary goal of SCI therapies focusses on the regeneration of neurons,
neurotrophins that aid the regeneration and migration of neurons are the factors most
likely to be beneficial to repair<sup><xref rid="bibr67-0963689718759472" ref-type="bibr">67</xref>,<xref rid="bibr81-0963689718759472" ref-type="bibr">81</xref></sup>. One candidate neurotrophin beneficial to repair might be NT-3. It has been
demonstrated that transplanted OECs genetically modified to produce high amounts of NT-3
cause significantly greater axonal regeneration and neuronal sprouting in a thoracic 9
contusion SCI site than control OECs<sup><xref rid="bibr51-0963689718759472" ref-type="bibr">51</xref></sup>. Furthermore, in RGCs, BDNF has been shown to stimulate thicker cellular processes,
greatly increase migration, and extend survival of RGCs following injury suggesting that
the same effects may be seen in neurons found in an SCI site<sup><xref rid="bibr77-0963689718759472" ref-type="bibr">77</xref></sup>. Fibroblast growth factor 2 (FGF2) has been shown to play a role in neuronal
maturation which may also be applied to a SCI site for therapeutic benefit. Similarly,
FGF2 (25 ng/mL) has been shown to stimulate the maturation of bipolar ganglionic cells
from embryonic rat cochlear ganglion tissue<sup><xref rid="bibr82-0963689718759472" ref-type="bibr">82</xref>,<xref rid="bibr83-0963689718759472" ref-type="bibr">83</xref></sup>.</p>
      </sec>
      <sec id="section14-0963689718759472">
        <title>Astrocytes within the SCI Site</title>
        <p>One of the features that makes OECs a valuable transplant candidate for further
investigation is that they possess the unique ability to interact with astrocytes while
other glial cells do not<sup><xref rid="bibr3-0963689718759472" ref-type="bibr">3</xref></sup>. This phenotype is attributed to the interaction of FGF2 and heparin molecules on
the target cells, which are cell-type specific<sup><xref rid="bibr82-0963689718759472" ref-type="bibr">82</xref>,<xref rid="bibr84-0963689718759472" ref-type="bibr">84</xref></sup>. In contrast, SCs do not naturally interact with astrocytes. However, inhibition of
FGFR1, which specifically inhibits the binding of FGF2, leads to an increased mingling of
SCs with astrocytes. Additionally, the use of heparinase (a heparin sulfate digestive
enzyme) results in the removal of the boundary between the 2 cell types<sup><xref rid="bibr3-0963689718759472" ref-type="bibr">3</xref>,<xref rid="bibr85-0963689718759472" ref-type="bibr">85</xref>,<xref rid="bibr86-0963689718759472" ref-type="bibr">86</xref></sup>. The degradation of the boundary between SCs and astrocytes is due to the
interaction of FGF with the heparin sulfate proteoglycan profile of which SCs and OECs are different<sup><xref rid="bibr3-0963689718759472" ref-type="bibr">3</xref></sup>. These results show that while neurotrophins play a beneficial role for 1 cell
type, such as promoting survival or migration of OECs, in other circumstances they can be
detrimental to the efforts of SCI treatment, for example, by preventing cell
integration.</p>
      </sec>
      <sec id="section15-0963689718759472">
        <title>Oligodendrocytes within the SCI Site</title>
        <p>Following SCI, a large number of oligodendrocytes die<sup><xref rid="bibr49-0963689718759472" ref-type="bibr">49</xref></sup>. Stimulating the survival or proliferation of these cells to support recovering
neurons through remyelination and continued survival could be an important step in SCI
recovery. It has previously been shown that EGF (20 ng/mL) when applied to injured
oligodendrocytes can stimulate the outgrowth of myelinating lamellipodial processes<sup><xref rid="bibr87-0963689718759472" ref-type="bibr">87</xref></sup>. Interestingly, this feature is not seen in developing or mature oligodendrocytes,
only in damaged cells. Conversely, EGF has been demonstrated to suppress the expression of
myelin basic protein expression in developing oligodendrocytes and could cause issues with
oligodendrocyte precursors found within the SCI site<sup><xref rid="bibr1-0963689718759472" ref-type="bibr">1</xref>,<xref rid="bibr88-0963689718759472" ref-type="bibr">88</xref></sup>.</p>
      </sec>
      <sec id="section16-0963689718759472">
        <title>Angiogenesis within the SCI Site</title>
        <p>As previously discussed, GDNF would be a useful candidate for a coadministrative approach
to transplantation. However, GDNF also possesses properties that would be beneficial after
the cells have been transplanted, both for the transplanted cells and for the cells at the
injury site. The role of angiogenesis in SCI repair is often overlooked; however, the
reinnervation of blood supply to regenerating tissue is important for supporting the newly
generating neurons and glia. While OECs have previously been shown to encourage angiogenesis<sup><xref rid="bibr89-0963689718759472" ref-type="bibr">89</xref></sup>, GDNF additionally stimulates an increase in the number of blood vessels compared
to a control<sup><xref rid="bibr19-0963689718759472" ref-type="bibr">19</xref>,<xref rid="bibr39-0963689718759472" ref-type="bibr">39</xref></sup>. Similarly, NGF and VEGF demonstrate an ability to stimulate angiogenesis. NGF
demonstrates an ability to increase angiogenesis in ischemic hindlimbs<sup><xref rid="bibr90-0963689718759472" ref-type="bibr">90</xref></sup>, and VEGF can stimulate vascular sprouting in endothelial cells when under hypoxic conditions<sup><xref rid="bibr91-0963689718759472" ref-type="bibr">91</xref><xref rid="bibr92-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr93-0963689718759472" ref-type="bibr">93</xref></sup>.</p>
        <p>A variety of neurotrophins could be applied to the SCI therapy. As autologous OECs
constitute a promising therapy option, supporting them following transplantation using
NGF, BDNF, NT-3, and GDNF may improve the efficacy of this treatment. Additionally, by
influencing cell comingling and angiogenesis using the FGF family of neurotrophins, VEGF,
and GDNF, it may be possible to further support the SCI site by improving nutrient
innervation within the damaged tissues. If effects of neurotrophins on different cell
types in a multicellular environment can be defined, the outcomes may also pave the way
for enhancing therapies using other transplanted cell types, such as SCs,
oligodendrocytes, and neural stem cells, perhaps in combination with OECs. Neurons, SCs,
and oligodendrocytes all express a different profile of neurotrophin receptors as shown in
<xref rid="table1-0963689718759472" ref-type="table">Table 1</xref>.</p>
      </sec>
    </sec>
    <sec id="section17-0963689718759472">
      <title>Future Avenues for Optimization of OEC Transplantation Using Neurotrophins</title>
      <p>The neurotrophins discussed in this review and their potential applications in SCI
therapies offer an avenue by which the therapeutic potential of transplanted OECs may be
significantly enhanced. However, the process of defining a cocktail of neurotrophins to be
used to complement OEC transplantation may be hindered by unforeseen interactions between
these different proteins. For this reason, the application of neurotrophins in phases may
provide the least complications with this treatment. Additionally, application outside of
these proposed phases may further aid the patient, for example, as an emergency application
following injury or used prior to biopsy so that the greatest yield of functional cells can
be achieved.</p>
      <sec id="section18-0963689718759472">
        <title>Compounding Neurotrophic Effects</title>
        <p>As discussed so far, there are several neurotrophins that are applicable in different
stages of the transplantation process; however, examining the compounding effects of these
different neurotrophins has not been thoroughly investigated. Understanding how
neurotrophins interact with each other may provide insight into how to achieve the
greatest effect. For example, when exposed to FGF2, platelet-derived growth factor
receptor alpha (PDGFR&#x3B1;) expression has been shown to increase. When FGF2 administration
was followed with PDGF administration, the resulting increase of mitogenic activity was
30% greater than PDGF alone<sup><xref rid="bibr94-0963689718759472" ref-type="bibr">94</xref></sup>. Similarly, EGF has shown altered effects when combined with another growth factor.
EGF (10 ng/mL) has been shown to promote cell proliferation and differentiation within the
basal olfactory neuroepithelium. However, when transforming growth factor beta (TGF&#x3B2;-2) is
used in conjunction with EGF, neuron differentiation is stimulated whereas EGF alone
encourages fibroblast differentiation<sup><xref rid="bibr33-0963689718759472" ref-type="bibr">33</xref>,<xref rid="bibr95-0963689718759472" ref-type="bibr">95</xref></sup>. By exploring the use of EGF with varying levels of TGF&#x3B2;-2, it may be possible to
cotransplant OECs and basal cells and then further differentiate neurons and fibroblasts
gradually in the days following transplantation, replicating the regenerative abilities of
the olfactory system at the level of the cytoenvironment.</p>
        <p>The modulation of neurotrophic factor receptors by other neurotrophins is an area that
requires further research. As many of the target cells possess more than a single
neurotrophin receptor, understanding the interplay between these receptors could prove
important in the division of an effective treatment. Several of the signaling pathways for
different neurotrophins share elements (<xref ref-type="fig" rid="fig4-0963689718759472">Fig. 4</xref>). In particular, the GRB2-SOS-Ras-Raf-MEK-ERK pathway is shared by all
neurotrophins. There are also other similarities such as PDGFR&#x3B1;, VEGFR2, and TrkB
signaling via phospholipase C gamma-protein kinase C (PLC&#x3B3;-PKC), and TrkA, and GFR&#x3B1;1/Ret
signaling via RAC1-RhoA. While what is presented in <xref ref-type="fig" rid="fig4-0963689718759472">Fig. 4</xref> is a simplified signaling map, it demonstrates
the crossover between several neurotrophin signaling cascades and so interaction between
these proteins should be further characterized before being applied in future treatments<sup><xref rid="bibr32-0963689718759472" ref-type="bibr">32</xref>,<xref rid="bibr52-0963689718759472" ref-type="bibr">52</xref><xref rid="bibr53-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr54-0963689718759472" ref-type="bibr">54</xref>,<xref rid="bibr96-0963689718759472" ref-type="bibr">96</xref><xref rid="bibr97-0963689718759472" ref-type="bibr"/>&#x2013;<xref rid="bibr98-0963689718759472" ref-type="bibr">98</xref></sup>.</p>
        <fig id="fig4-0963689718759472" orientation="portrait" position="float">
          <label>Fig. 4.</label>
          <caption>
            <p>Simplified pathway map of the neurotrophic signaling cascades described in this
review and their subsequent effects. <italic>Source</italic>: Adapted from references
32, 52&#x2013;54, and 96&#x2013;98.</p>
          </caption>
          <graphic xlink:href="10.1177_0963689718759472-fig4"/>
        </fig>
      </sec>
      <sec id="section19-0963689718759472">
        <title>Neurotrophins for Emergency Administration</title>
        <p>As with many acute injuries, addressing an SCI quickly following injury yields the
greatest functional outcome. However, beyond providing therapeutic hypothermia<sup><xref rid="bibr99-0963689718759472" ref-type="bibr">99</xref></sup>, there is little that can be done to diminish the secondary damage that will occur
following SCI. However, neurotrophins may be suited to decreasing this secondary damage
when applied acutely. The dual &#x3B2;-subunit of PDGF (PDGF-BB) has been previously used to
ameliorate ischemic stroke damage in a dose-dependent manner. Additionally, PDGF-BB has
been shown to decrease neuronal death in forebrain ischemia, improving ischemic outcome.
While this has not been investigated in the spinal cord, these anti-ischemic properties of
PDGF may be translatable to SCI<sup><xref rid="bibr100-0963689718759472" ref-type="bibr">100</xref></sup>. An interesting combinatorial effect of PDGF with VEGF has been observed for acute
SCI, where the combination of the 2 growth factors resulted in a dramatic reduction of
secondary degeneration compared to when either growth factor alone was applied to the
injury site<sup><xref rid="bibr101-0963689718759472" ref-type="bibr">101</xref>,<xref rid="bibr102-0963689718759472" ref-type="bibr">102</xref></sup>. This combinatorial effect of growth factors highlights the importance of
considering multiple outcomes on different cell types when using growth factors.</p>
      </sec>
    </sec>
    <sec sec-type="conclusions" id="section20-0963689718759472">
      <title>Conclusion</title>
      <p>OEC transplantation is a very promising therapy for SCI; however, results are highly
variable and the method needs improvement. Neurotrophins can stimulate favorable behaviors
in OECs, such as proliferation, migration, phagocytosis, and interaction with other cells.
Prior to transplantation, neurotrophins can be used to optimize the health, quality, and
purity of OECs. Coadministration of neurotrophins with OECs at the time of transplantation
may also be beneficial; here, the neuroprotective factors NGF and NT-3 are likely
candidates. GDNF can also be used in this stage of treatment, by aiding the migration and
integration of OECs into the SCI site. Finally, neurotrophins may be used as general support
for the SCI environment in the longer term. NT-3 (neuroprotection), BDNF (neuronal
survival), FGF2 (astrocyte&#x2013;OEC integration), NGF, GDNF, VEGF, and PDGF (vascularization) are
all promising candidates for this purpose (<xref ref-type="fig" rid="fig5-0963689718759472">Fig. 5</xref>).</p>
      <fig id="fig5-0963689718759472" orientation="portrait" position="float">
        <label>Fig. 5.</label>
        <caption>
          <p>Summary of neurotrophins and their application in spinal cord injury (SCI). The
potential roles for key neurotrophins during the 3 phases of olfactory ensheathing cell
(OEC) transplantation therapy for SCI (cell preparation, cell administration, and
continuous support). OEC preparation may be enhanced using neurotrophin 3 (NT-3) and
nerve growth factor (NGF). Cell administration may be supported using NT-3, NGF,
glial-derived neurotrophic factor (GDNF), and brain-derived neurotrophic factor (BDNF).
Ongoing support to the injury/transplantation site may be achieved through the use of
NT-3, fibroblast growth factor 2 (FGF2), epidermal growth factor (EGF), GDNF, vascular
endothelial growth factor (VEGF), and platelet-derived growth factor (PDGF).</p>
        </caption>
        <graphic xlink:href="10.1177_0963689718759472-fig5"/>
      </fig>
      <p>Using neurotrophin manipulation, it may be possible to adjust the phenotype and behaviors
of OEC into those most beneficial for SCI repair. Determining how neurotrophins modulate
OECs and cell types endogenous to the injury site is therefore highly warranted.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="COI-statement" id="fn6-0963689718759472">
        <p><bold>Declaration of Conflicting Interests:</bold> The authors declared no potential conflicts of interest with respect to the research,
authorship, and/or publication of this article.</p>
      </fn>
      <fn fn-type="financial-disclosure" id="fn7-0963689718759472">
        <p><bold>Funding:</bold> The authors disclosed receipt of the following financial support for the research,
authorship, and/or publication of this article: This work was supported by a Perry Cross
Spinal Research Foundation grant to JSJ and JE, an ARC Discovery grant (DP150104495) to JE
and JSJ, a Motor Accident Insurance Commission of Queensland grant to JSJ and JE and a
Clem Jones Foundation grant to JSJ. The granting bodies had no role in the experimental
design, interpretation, and writing of the report or decision to submit the article.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="bibr1-0963689718759472">
        <label>1</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baldoino Leal-Filho</surname><given-names>M</given-names></name></person-group>
<article-title>Spinal cord injury: from inflammation to glial
scar</article-title>. <source>Surg Neurol Int</source>.
<year>2011</year>;<volume>2</volume>:<fpage>112</fpage>.<pub-id pub-id-type="pmid">21886885</pub-id></mixed-citation>
      </ref>
      <ref id="bibr2-0963689718759472">
        <label>2</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>JE</given-names></name><name><surname>Imura</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>B</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Ao</surname><given-names>Y</given-names></name><name><surname>Nguyen</surname><given-names>TK</given-names></name><name><surname>Korsak</surname><given-names>RA</given-names></name><name><surname>Takeda</surname><given-names>K</given-names></name><name><surname>Akira</surname><given-names>S</given-names></name><name><surname>Sofroniew</surname><given-names>MV</given-names></name></person-group>
<article-title>STAT3 is a critical regulator of astrogliosis and scar
formation after spinal cord injury</article-title>. <source>J Neurosci</source>.
<year>2008</year>;<volume>28</volume>(<issue>28</issue>):<fpage>7231</fpage>&#x2013;<lpage>7243</lpage>.<pub-id pub-id-type="pmid">18614693</pub-id></mixed-citation>
      </ref>
      <ref id="bibr3-0963689718759472">
        <label>3</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santos-Silva</surname><given-names>A</given-names></name><name><surname>Fairless</surname><given-names>R</given-names></name><name><surname>Frame</surname><given-names>MC</given-names></name><name><surname>Montague</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>GM</given-names></name><name><surname>Toft</surname><given-names>A</given-names></name><name><surname>Riddell</surname><given-names>JS</given-names></name><name><surname>Barnett</surname><given-names>SC</given-names></name></person-group>
<article-title>FGF/heparin differentially regulates Schwann cell and
olfactory ensheathing cell interactions with astrocytes: a role in
astrocytosis</article-title>. <source>J Neurosci</source>.
<year>2007</year>;<volume>27</volume>(<issue>27</issue>):<fpage>7154</fpage>&#x2013;<lpage>7167</lpage>.<pub-id pub-id-type="pmid">17611269</pub-id></mixed-citation>
      </ref>
      <ref id="bibr4-0963689718759472">
        <label>4</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Domeniconi</surname><given-names>M</given-names></name><name><surname>Hempstead</surname><given-names>BL</given-names></name><name><surname>Chao</surname><given-names>M V</given-names></name></person-group>
<article-title>Pro-NGF secreted by astrocytes promotes motor neuron cell
death</article-title>. <source>Mol Cell Neurosci</source>.
<year>2007</year>;<volume>34</volume>(<issue>2</issue>):<fpage>271</fpage>&#x2013;<lpage>279</lpage>.<pub-id pub-id-type="pmid">17188890</pub-id></mixed-citation>
      </ref>
      <ref id="bibr5-0963689718759472">
        <label>5</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mackay-Sim</surname><given-names>A</given-names></name></person-group>
<article-title>Olfactory ensheathing cells and spinal cord
repair</article-title>. <source>Keio J Med</source>.
<year>2005</year>;<volume>54</volume>(<issue>1</issue>):<fpage>8</fpage>&#x2013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">15832075</pub-id></mixed-citation>
      </ref>
      <ref id="bibr6-0963689718759472">
        <label>6</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Windus</surname><given-names>LCE</given-names></name><name><surname>Claxton</surname><given-names>C</given-names></name><name><surname>Allen</surname><given-names>CL</given-names></name><name><surname>Key</surname><given-names>B</given-names></name><name><surname>St. John</surname><given-names>JA</given-names></name></person-group>
<article-title>Motile membrane protrusions regulate cell-cell adhesion
and migration of olfactory ensheathing glia</article-title>. <source>Glia</source>.
<year>2007</year>;<volume>55</volume>(<issue>14</issue>):<fpage>1708</fpage>&#x2013;<lpage>1719</lpage>.<pub-id pub-id-type="pmid">17893920</pub-id></mixed-citation>
      </ref>
      <ref id="bibr7-0963689718759472">
        <label>7</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Granger</surname><given-names>N</given-names></name><name><surname>Blamires</surname><given-names>H</given-names></name><name><surname>Franklin</surname><given-names>RJM</given-names></name><name><surname>Jeffery</surname><given-names>ND</given-names></name></person-group>
<article-title>Autologous olfactory mucosal cell transplants in clinical
spinal cord injury: a randomized double-blinded trial in a canine translational
model</article-title>. <source>Brain</source>.
<year>2012</year>;<volume>135</volume>(<issue>11</issue>):<fpage>3227</fpage>&#x2013;<lpage>3237</lpage>.<pub-id pub-id-type="pmid">23169917</pub-id></mixed-citation>
      </ref>
      <ref id="bibr8-0963689718759472">
        <label>8</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Feron</surname><given-names>F</given-names></name><name><surname>Perry</surname><given-names>C</given-names></name><name><surname>Cochrane</surname><given-names>J</given-names></name><name><surname>Licina</surname><given-names>P</given-names></name><name><surname>Nowitzke</surname><given-names>A</given-names></name><name><surname>Urquhart</surname><given-names>S</given-names></name><name><surname>Geraghty</surname><given-names>T</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name></person-group>
<article-title>Autologous olfactory ensheathing cell transplantation in
human spinal cord injury</article-title>. <source>Brain</source>.
<year>2005</year>;<volume>128</volume>(<issue>12</issue>):<fpage>2951</fpage>&#x2013;<lpage>2960</lpage>.<pub-id pub-id-type="pmid">16219671</pub-id></mixed-citation>
      </ref>
      <ref id="bibr9-0963689718759472">
        <label>9</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Keyvan-Fouladi</surname><given-names>N</given-names></name><name><surname>Raisman</surname><given-names>G</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name></person-group>
<article-title>Functional repair of the corticospinal tract by delayed
transplantation of olfactory ensheathing cells in adult rats</article-title>. <source>J
Neurosci</source>.
<year>2003</year>;<volume>23</volume>(<issue>28</issue>):<fpage>9428</fpage>&#x2013;<lpage>9434</lpage>.<pub-id pub-id-type="pmid">14561871</pub-id></mixed-citation>
      </ref>
      <ref id="bibr10-0963689718759472">
        <label>10</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tabakow</surname><given-names>P</given-names></name><name><surname>Raisman</surname><given-names>G</given-names></name><name><surname>Fortuna</surname><given-names>W</given-names></name><name><surname>Czyz</surname><given-names>M</given-names></name><name><surname>Huber</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Szewczyk</surname><given-names>P</given-names></name><name><surname>Okurowski</surname><given-names>S</given-names></name><name><surname>Miedzybrodzki</surname><given-names>R</given-names></name><name><surname>Czapiga</surname><given-names>B</given-names></name><name><surname>Salomon</surname><given-names>B</given-names></name><name><surname>Halon</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lipiec</surname><given-names>J</given-names></name><name><surname>Kulczyk</surname><given-names>A</given-names></name><name><surname>Jarmundowicz</surname><given-names>W</given-names></name></person-group>
<article-title>Functional regeneration of supraspinal connections in a
patient with transected spinal cord following transplantation of bulbar olfactory
ensheathing cells with peripheral nerve bridging</article-title>. <source>Cell
Transplant</source>.
<year>2014</year>;<volume>23</volume>(<issue>12</issue>):<fpage>1631</fpage>&#x2013;<lpage>1655</lpage>.<pub-id pub-id-type="pmid">25338642</pub-id></mixed-citation>
      </ref>
      <ref id="bibr11-0963689718759472">
        <label>11</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cordero</surname><given-names>MI</given-names></name><name><surname>Santos-Benito</surname><given-names>FF</given-names></name></person-group>
<article-title>Functional recovery of paraplegic rats and motor axon
regeneration in their spinal cords by olfactory ensheathing glia</article-title>.
<source>Neuron</source>.
<year>2000</year>;<volume>25</volume>(<issue>2</issue>):<fpage>425</fpage>&#x2013;<lpage>435</lpage>.<pub-id pub-id-type="pmid">10719896</pub-id></mixed-citation>
      </ref>
      <ref id="bibr12-0963689718759472">
        <label>12</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Windus</surname><given-names>LCE</given-names></name><name><surname>Lineburg</surname><given-names>KE</given-names></name><name><surname>Scott</surname><given-names>SE</given-names></name><name><surname>Claxton</surname><given-names>C</given-names></name><name><surname>MacKay-Sim</surname><given-names>A</given-names></name><name><surname>Key</surname><given-names>B</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name></person-group>
<article-title>Lamellipodia mediate the heterogeneity of central
olfactory ensheathing cell interactions</article-title>. <source>Cell Mol Life
Sci</source>.
<year>2010</year>;<volume>67</volume>(<issue>10</issue>):<fpage>1735</fpage>&#x2013;<lpage>1750</lpage>.<pub-id pub-id-type="pmid">20143249</pub-id></mixed-citation>
      </ref>
      <ref id="bibr13-0963689718759472">
        <label>13</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gilad</surname><given-names>Y</given-names></name><name><surname>Lancet</surname><given-names>D</given-names></name></person-group>
<article-title>Population differences in the human functional olfactory
repertoire</article-title>. <source>Mol Biol Evol</source>.
<year>2003</year>;<volume>20</volume>(<issue>3</issue>):<fpage>307</fpage>&#x2013;<lpage>314</lpage>.<pub-id pub-id-type="pmid">12644552</pub-id></mixed-citation>
      </ref>
      <ref id="bibr14-0963689718759472">
        <label>14</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ekberg</surname><given-names>JAK</given-names></name><name><surname>Amaya</surname><given-names>D</given-names></name><name><surname>MacKay-Sim</surname><given-names>A</given-names></name><name><surname>St. John</surname><given-names>JA</given-names></name></person-group>
<article-title>The migration of olfactory ensheathing cells during
development and regeneration</article-title>. <source>NeuroSignals</source>.
<year>2012</year>;<volume>20</volume>(<issue>3</issue>):<fpage>147</fpage>&#x2013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">22456085</pub-id></mixed-citation>
      </ref>
      <ref id="bibr15-0963689718759472">
        <label>15</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ekberg</surname><given-names>JAK</given-names></name><name><surname>St. John</surname><given-names>JA</given-names></name></person-group>
<article-title>Crucial roles for olfactory ensheathing cells and
olfactory mucosal cells in the repair of damaged neural tracts</article-title>.
<source>Anat Rec (Hoboken)</source>.
<year>2014</year>;<volume>297</volume>(<issue>1</issue>):<fpage>121</fpage>&#x2013;<lpage>128</lpage>.<pub-id pub-id-type="pmid">24293406</pub-id></mixed-citation>
      </ref>
      <ref id="bibr16-0963689718759472">
        <label>16</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nazareth</surname><given-names>L</given-names></name><name><surname>Lineburg</surname><given-names>KE</given-names></name><name><surname>Chuah</surname><given-names>MI</given-names></name><name><surname>Tello Velasquez</surname><given-names>J</given-names></name><name><surname>Chehrehasa</surname><given-names>F</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name><name><surname>Ekberg</surname><given-names>JAK</given-names></name></person-group>
<article-title>Olfactory ensheathing cells are the main phagocytic cells
that remove axon debris during early development of the olfactory
system</article-title>. <source>J Comp Neurol</source>.
<year>2015</year>;<volume>523</volume>(<issue>3</issue>):<fpage>479</fpage>&#x2013;<lpage>494</lpage>.<pub-id pub-id-type="pmid">25312022</pub-id></mixed-citation>
      </ref>
      <ref id="bibr17-0963689718759472">
        <label>17</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Qiu</surname><given-names>Y</given-names></name><name><surname>Yuan</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Pu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group>
<article-title>Olfactory ensheathing cells: the primary innate
immunocytes in the olfactory pathway to engulf apoptotic olfactory nerve
debris</article-title>. <source>Glia</source>.
<year>2013</year>;<volume>61</volume>(<issue>4</issue>):<fpage>490</fpage>&#x2013;<lpage>503</lpage>.<pub-id pub-id-type="pmid">23339073</pub-id></mixed-citation>
      </ref>
      <ref id="bibr18-0963689718759472">
        <label>18</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Panni</surname><given-names>P</given-names></name><name><surname>Ferguson</surname><given-names>IA</given-names></name><name><surname>Beacham</surname><given-names>I</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>Ekberg</surname><given-names>JAK</given-names></name><name><surname>St. John</surname><given-names>JA</given-names></name></person-group>
<article-title>Phagocytosis of bacteria by olfactory ensheathing cells
and Schwann cells</article-title>. <source>Neurosci Lett</source>.
<year>2013</year>;<volume>539</volume>:<fpage>65</fpage>&#x2013;<lpage>70</lpage>.<pub-id pub-id-type="pmid">23415759</pub-id></mixed-citation>
      </ref>
      <ref id="bibr19-0963689718759472">
        <label>19</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>He</surname><given-names>BR</given-names></name><name><surname>Hao</surname><given-names>DJ</given-names></name></person-group>
<article-title>Biological roles of olfactory ensheathing cells in
facilitating neural regeneration: a systematic review</article-title>. <source>Mol
Neurobiol</source>.
<year>2015</year>;<volume>51</volume>(<issue>1</issue>):<fpage>168</fpage>&#x2013;<lpage>179</lpage>.<pub-id pub-id-type="pmid">24615159</pub-id></mixed-citation>
      </ref>
      <ref id="bibr20-0963689718759472">
        <label>20</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Au</surname><given-names>E</given-names></name><name><surname>Richter</surname><given-names>MW</given-names></name><name><surname>Vincent</surname><given-names>AJ</given-names></name><name><surname>Tetzlaff</surname><given-names>W</given-names></name><name><surname>Aebersold</surname><given-names>R</given-names></name><name><surname>Sage</surname><given-names>EH</given-names></name><name><surname>Roskams</surname><given-names>AJ</given-names></name></person-group>
<article-title>SPARC from olfactory ensheathing cells stimulates Schwann
cells to promote neurite outgrowth and enhances spinal cord repair</article-title>.
<source>J Neurosci</source>.
<year>2007</year>;<volume>27</volume>(<issue>27</issue>):<fpage>7208</fpage>&#x2013;<lpage>7221</lpage>.<pub-id pub-id-type="pmid">17611274</pub-id></mixed-citation>
      </ref>
      <ref id="bibr21-0963689718759472">
        <label>21</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Yan-Ling</surname><given-names>Z</given-names></name><name><surname>Zhida</surname><given-names>S</given-names></name><name><surname>Baolai</surname><given-names>L</given-names></name><name><surname>Zhihui</surname><given-names>H</given-names></name><name><surname>Lifang</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name></person-group>
<article-title>Olfactory ensheathing cells promote migration of Schwann
cells by secreted nerve growth factor</article-title>. <source>Glia</source>.
<year>2007</year>;<volume>55</volume>(<issue>14</issue>):<fpage>897</fpage>&#x2013;<lpage>904</lpage>.<pub-id pub-id-type="pmid">17405147</pub-id></mixed-citation>
      </ref>
      <ref id="bibr22-0963689718759472">
        <label>22</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chehrehasa</surname><given-names>F</given-names></name><name><surname>Windus</surname><given-names>LCE</given-names></name><name><surname>Ekberg</surname><given-names>JAK</given-names></name><name><surname>Scott</surname><given-names>SE</given-names></name><name><surname>Amaya</surname><given-names>D</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name></person-group>
<article-title>Olfactory glia enhance neonatal axon
regeneration</article-title>. <source>Mol Cell Neurosci</source>.
<year>2010</year>;<volume>45</volume>(<issue>3</issue>):<fpage>277</fpage>&#x2013;<lpage>288</lpage>.<pub-id pub-id-type="pmid">20621189</pub-id></mixed-citation>
      </ref>
      <ref id="bibr23-0963689718759472">
        <label>23</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>EJ</given-names></name><name><surname>Wilkinson</surname><given-names>GA</given-names></name><name><surname>Fari&#xF1;as</surname><given-names>I</given-names></name><name><surname>Backus</surname><given-names>C</given-names></name><name><surname>Zang</surname><given-names>K</given-names></name><name><surname>Wong</surname><given-names>SL</given-names></name><name><surname>Reichardt</surname><given-names>LF</given-names></name></person-group>
<article-title>Expression of Trk receptors in the developing mouse
trigeminal ganglion: in vivo evidence for NT-3 activation of TrkA and TrkB in addition
to TrkC</article-title>. <source>Development</source>.
<year>1999</year>;<volume>126</volume>(<issue>10</issue>):<fpage>2191</fpage>&#x2013;<lpage>203</lpage>.<pub-id pub-id-type="pmid">10207144</pub-id></mixed-citation>
      </ref>
      <ref id="bibr24-0963689718759472">
        <label>24</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cosgaya</surname><given-names>JM</given-names></name><name><surname>Chan</surname><given-names>JR</given-names></name><name><surname>Shooter</surname><given-names>EM</given-names></name></person-group>
<article-title>The neurotrophin receptor p75NTR as a positive modulator
of myelination</article-title>. <source>Science</source>.
<year>2002</year>;<volume>298</volume>(<issue>5596</issue>):<fpage>1245</fpage>&#x2013;<lpage>1248</lpage>.<pub-id pub-id-type="pmid">12424382</pub-id></mixed-citation>
      </ref>
      <ref id="bibr25-0963689718759472">
        <label>25</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yamauchi</surname><given-names>J</given-names></name><name><surname>Chan</surname><given-names>JR</given-names></name><name><surname>Shooter</surname><given-names>EM</given-names></name></person-group>
<article-title>Neurotrophins regulate Schwann cell migration by
activating divergent signaling pathways dependent on Rho GTPases</article-title>.
<source>Proc Natl Acad Sci U S A</source>.
<year>2004</year>;<volume>101</volume>(<issue>23</issue>):<fpage>8774</fpage>&#x2013;<lpage>8779</lpage>.<pub-id pub-id-type="pmid">15161978</pub-id></mixed-citation>
      </ref>
      <ref id="bibr26-0963689718759472">
        <label>26</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vickland</surname><given-names>H</given-names></name><name><surname>Westrum</surname><given-names>LE</given-names></name><name><surname>Kott</surname><given-names>JN</given-names></name><name><surname>Patterson</surname><given-names>SL</given-names></name><name><surname>Bothwell</surname><given-names>MA</given-names></name></person-group>
<article-title>Nerve growth factor receptor expression in the young and
adult rat olfactory system</article-title>. <source>Brain Res</source>.
<year>1991</year>;<volume>565</volume>(<issue>2</issue>):<fpage>269</fpage>&#x2013;<lpage>279</lpage>.<pub-id pub-id-type="pmid">1842697</pub-id></mixed-citation>
      </ref>
      <ref id="bibr27-0963689718759472">
        <label>27</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trupp</surname><given-names>M</given-names></name><name><surname>Belluardo</surname><given-names>N</given-names></name><name><surname>Funakoshi</surname><given-names>H</given-names></name><name><surname>Ib&#xE1;&#xF1;ez</surname><given-names>CF</given-names></name></person-group>
<article-title>Complementary and overlapping expression of glial cell
line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha
indicates multiple mechanisms of trophic actions in the adult rat CNS</article-title>.
<source>J Neurosci</source>.
<year>1997</year>;<volume>17</volume>(<issue>10</issue>):<fpage>3554</fpage>&#x2013;<lpage>3567</lpage>.<pub-id pub-id-type="pmid">9133379</pub-id></mixed-citation>
      </ref>
      <ref id="bibr28-0963689718759472">
        <label>28</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Trupp</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>R</given-names></name><name><surname>Whittemore</surname><given-names>SR</given-names></name><name><surname>Ibanez</surname><given-names>CF</given-names></name></person-group>
<article-title>Ret-dependent and -independent mechanisms of glial cell
line-derived neurotrophic factor signaling in neuronal cells</article-title>. <source>J
Biol Chem</source>.
<year>1999</year>;<volume>274</volume>(<issue>30</issue>):<fpage>20885</fpage>&#x2013;<lpage>20894</lpage>.<pub-id pub-id-type="pmid">10409632</pub-id></mixed-citation>
      </ref>
      <ref id="bibr29-0963689718759472">
        <label>29</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>Z</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Lv</surname><given-names>B</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Jiao</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Huang</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>C</given-names></name></person-group>
<article-title>Glia cell line-derived neurotrophic factor promotes
olfactory ensheathing cells migration</article-title>. <source>Glia</source>.
<year>2006</year>;(<issue>54</issue>):<fpage>536</fpage>&#x2013;<lpage>544</lpage>.<pub-id pub-id-type="pmid">16906542</pub-id></mixed-citation>
      </ref>
      <ref id="bibr30-0963689718759472">
        <label>30</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Huang</surname><given-names>EJ</given-names></name><name><surname>Zang</surname><given-names>K</given-names></name><name><surname>Schmidt</surname><given-names>A</given-names></name><name><surname>Saulys</surname><given-names>A</given-names></name><name><surname>Xiang</surname><given-names>M</given-names></name><name><surname>Reichardt</surname><given-names>LF</given-names></name></person-group>
<article-title>POU domain factor Brn-3a controls the differentiation and
survival of trigeminal neurons by regulating Trk receptor expression</article-title>.
<source>Development</source>.
<year>1999</year>;<volume>126</volume>(<issue>13</issue>):<fpage>2869</fpage>&#x2013;<lpage>2882</lpage>.<pub-id pub-id-type="pmid">10357931</pub-id></mixed-citation>
      </ref>
      <ref id="bibr31-0963689718759472">
        <label>31</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Widenfalk</surname><given-names>J</given-names></name><name><surname>Lipson</surname><given-names>A</given-names></name><name><surname>Jubran</surname><given-names>M</given-names></name><name><surname>Hofstetter</surname><given-names>C</given-names></name><name><surname>Ebendal</surname><given-names>T</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name></person-group>
<article-title>Vascular endothelial growth factor improves functional
outcome and decreases secondary degeneration in experimental spinal cord contusion
injury</article-title>. <source>Neuroscience</source>.
<year>2003</year>;<volume>120</volume>(<issue>4</issue>):<fpage>951</fpage>&#x2013;<lpage>960</lpage>.<pub-id pub-id-type="pmid">12927201</pub-id></mixed-citation>
      </ref>
      <ref id="bibr32-0963689718759472">
        <label>32</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koch</surname><given-names>S</given-names></name><name><surname>Claesson-Welsh</surname><given-names>L</given-names></name></person-group>
<article-title>Signal transduction by vascular endothelial growth factor
receptors</article-title>. <source>Cold Spring Harb Perspect Med</source>.
<year>2012</year>;<volume>2</volume>(<issue>7</issue>):<fpage>1</fpage>&#x2013;<lpage>21</lpage>.</mixed-citation>
      </ref>
      <ref id="bibr33-0963689718759472">
        <label>33</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Doetsch</surname><given-names>F</given-names></name><name><surname>Petreanu</surname><given-names>L</given-names></name><name><surname>Caille</surname><given-names>I</given-names></name><name><surname>Garcia-Verdugo</surname><given-names>JM</given-names></name><name><surname>Alvarez-Buylla</surname><given-names>A</given-names></name></person-group>
<article-title>EGF converts transit-amplifying neurogenic precursors in
the adult brain into multipotent stem cells</article-title>. <source>Neuron</source>.
<year>2002</year>;<volume>36</volume>(<issue>6</issue>):<fpage>1021</fpage>&#x2013;<lpage>1034</lpage>.<pub-id pub-id-type="pmid">12495619</pub-id></mixed-citation>
      </ref>
      <ref id="bibr34-0963689718759472">
        <label>34</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mazzoni</surname><given-names>IE</given-names></name><name><surname>Kenigsberg</surname><given-names>RL</given-names></name></person-group>
<article-title>Localization and characterization of epidermal
growth-factor receptors in the developing rat medial septal area in
culture</article-title>. <source>Brain Res</source>.
<year>1994</year>;<volume>656</volume>(<issue>1</issue>):<fpage>115</fpage>&#x2013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">7804824</pub-id></mixed-citation>
      </ref>
      <ref id="bibr35-0963689718759472">
        <label>35</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morikawa</surname><given-names>Y</given-names></name><name><surname>Ishihara</surname><given-names>Y</given-names></name><name><surname>Tohya</surname><given-names>K</given-names></name><name><surname>Kakudo</surname><given-names>K</given-names></name><name><surname>Seo</surname><given-names>MK</given-names></name><name><surname>Matsuura</surname><given-names>N</given-names></name></person-group>
<article-title>Expression of the fibroblast growth factor receptor-1 in
human normal tissues and tumors determined by a new monoclonal antibody</article-title>.
<source>Arch Pathol Lab Med</source>.
<year>1996</year>;<volume>120</volume>(<issue>5</issue>):<fpage>490</fpage>&#x2013;<lpage>496</lpage>.<pub-id pub-id-type="pmid">8639054</pub-id></mixed-citation>
      </ref>
      <ref id="bibr36-0963689718759472">
        <label>36</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hart</surname><given-names>IK</given-names></name><name><surname>Richardson</surname><given-names>WD</given-names></name><name><surname>Heldin</surname><given-names>CH</given-names></name><name><surname>Westermark</surname><given-names>B</given-names></name><name><surname>Raff</surname><given-names>MC</given-names></name></person-group>
<article-title>PDGF receptors on cells of the oligodendrocyte-type-2
astrocyte (O-2A) cell lineage</article-title>. <source>Development</source>.
<year>1989</year>;<volume>105</volume>(<issue>3</issue>):<fpage>595</fpage>&#x2013;<lpage>603</lpage>.<pub-id pub-id-type="pmid">2558873</pub-id></mixed-citation>
      </ref>
      <ref id="bibr37-0963689718759472">
        <label>37</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lipson</surname><given-names>AC</given-names></name><name><surname>Widenfalk</surname><given-names>J</given-names></name><name><surname>Lindqvist</surname><given-names>E</given-names></name><name><surname>Ebendal</surname><given-names>T</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name></person-group>
<article-title>Neurotrophic properties of olfactory ensheathing
glia</article-title>. <source>Exp Neurol</source>.
<year>2003</year>;<volume>180</volume>(<issue>2</issue>):<fpage>167</fpage>&#x2013;<lpage>171</lpage>.<pub-id pub-id-type="pmid">12684030</pub-id></mixed-citation>
      </ref>
      <ref id="bibr38-0963689718759472">
        <label>38</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>LF</given-names></name><name><surname>Doherty</surname><given-names>DH</given-names></name><name><surname>Lile</surname><given-names>JD</given-names></name><name><surname>Bektesh</surname><given-names>S</given-names></name><name><surname>Collins</surname><given-names>F</given-names></name></person-group>
<article-title>GDNF: a glial cell line-derived neurotrophic factor for
midbrain dopaminergic neurons</article-title>. <source>Science</source>.
<year>1993</year>;<volume>260</volume>(<issue>5111</issue>):<fpage>1130</fpage>&#x2013;<lpage>1132</lpage>.<pub-id pub-id-type="pmid">8493557</pub-id></mixed-citation>
      </ref>
      <ref id="bibr39-0963689718759472">
        <label>39</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Smith</surname><given-names>GM</given-names></name><name><surname>Wen</surname><given-names>X</given-names></name><name><surname>Pressman</surname><given-names>Y</given-names></name><name><surname>Wood</surname><given-names>PM</given-names></name><name><surname>Xu</surname><given-names>XM</given-names></name></person-group>
<article-title>GDNF-enhanced axonal regeneration and myelination
following spinal cord injury is mediated by primary effects on neurons</article-title>.
<source>Glia</source>.
<year>2009</year>;<volume>57</volume>(<issue>11</issue>):<fpage>1178</fpage>&#x2013;<lpage>1191</lpage>.<pub-id pub-id-type="pmid">19170182</pub-id></mixed-citation>
      </ref>
      <ref id="bibr40-0963689718759472">
        <label>40</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name></person-group>
<article-title>Olfactory ensheathing cells from the nose: clinical
application in human spinal cord injuries</article-title>. <source>Exp Neurol</source>.
<year>2011</year>;<volume>229</volume>(<issue>1</issue>):<fpage>174</fpage>&#x2013;<lpage>180</lpage>.<pub-id pub-id-type="pmid">20832402</pub-id></mixed-citation>
      </ref>
      <ref id="bibr41-0963689718759472">
        <label>41</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Field</surname><given-names>PM</given-names></name><name><surname>Raisman</surname><given-names>G</given-names></name></person-group>
<article-title>Olfactory ensheathing cells and olfactory nerve
fibroblasts maintain continuous open channels for regrowth of olfactory nerve
fibres</article-title>. <source>Glia</source>.
<year>2005</year>;<volume>52</volume>(<issue>3</issue>):<fpage>245</fpage>&#x2013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">15968636</pub-id></mixed-citation>
      </ref>
      <ref id="bibr42-0963689718759472">
        <label>42</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Higginson</surname><given-names>JR</given-names></name><name><surname>Barnett</surname><given-names>SC</given-names></name></person-group>
<article-title>The culture of olfactory ensheathing cells (OECs)&#x2014;a
distinct glial cell type</article-title>. <source>Exp Neurol</source>.
<year>2011</year>;<volume>229</volume>(<issue>1</issue>):<fpage>2</fpage>&#x2013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">20816825</pub-id></mixed-citation>
      </ref>
      <ref id="bibr43-0963689718759472">
        <label>43</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Song</surname><given-names>C</given-names></name><name><surname>Leonard</surname><given-names>BE</given-names></name></person-group>
<article-title>The olfactory bulbectomised rat as a model of
depression</article-title>. <source>Neurosci Biobehav Rev</source>.
<year>2005</year>;<volume>29</volume>(<issue>4&#x2013;5</issue>):<fpage>627</fpage>&#x2013;<lpage>647</lpage>.<pub-id pub-id-type="pmid">15925697</pub-id></mixed-citation>
      </ref>
      <ref id="bibr44-0963689718759472">
        <label>44</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Choi</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Law</surname><given-names>S</given-names></name><name><surname>Powell</surname><given-names>M</given-names></name><name><surname>Victor</surname><given-names>F</given-names></name><name><surname>Raisman</surname><given-names>G</given-names></name><name><surname>Horsley</surname><given-names>V</given-names></name></person-group>
<article-title>A prospective observational study of the yield of
olfactory ensheathing cells cultured from biopsies of septal nasal
mucosa</article-title>. <source>Neurosurgery</source>.
<year>2008</year>;<volume>62</volume>(<issue>5</issue>):<fpage>1140</fpage>&#x2013;<lpage>1145</lpage>.<pub-id pub-id-type="pmid">18580812</pub-id></mixed-citation>
      </ref>
      <ref id="bibr45-0963689718759472">
        <label>45</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mayeur</surname><given-names>A</given-names></name><name><surname>Duclos</surname><given-names>C</given-names></name><name><surname>Honor&#xE9;</surname><given-names>A</given-names></name><name><surname>Gauberti</surname><given-names>M</given-names></name><name><surname>Drouot</surname><given-names>L</given-names></name><name><surname>do Rego</surname><given-names>JC</given-names></name><name><surname>Bon-Mardion</surname><given-names>N</given-names></name><name><surname>Jean</surname><given-names>L</given-names></name><name><surname>V&#xE9;rin</surname><given-names>E</given-names></name><name><surname>Emery</surname><given-names>E</given-names></name><name><surname>Lemarchant</surname><given-names>S</given-names></name><name><surname>Vivien</surname><given-names>D</given-names></name><name><surname>Boyer</surname><given-names>O</given-names></name><name><surname>Marie</surname><given-names>JP</given-names></name><name><surname>Gu&#xE9;rout</surname><given-names>N</given-names></name></person-group>
<article-title>Potential of olfactory ensheathing cells from different
sources for spinal cord repair</article-title>. <source>PLoS One</source>.
<year>2013</year>;<volume>8</volume>(<issue>4</issue>).<fpage>e62860</fpage>.<pub-id pub-id-type="pmid">23638158</pub-id></mixed-citation>
      </ref>
      <ref id="bibr46-0963689718759472">
        <label>46</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bianco</surname><given-names>JI</given-names></name><name><surname>Perry</surname><given-names>C</given-names></name><name><surname>Harkin</surname><given-names>DG</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>F&#xE9;ron</surname><given-names>F</given-names></name></person-group>
<article-title>Neurotrophin 3 promotes purification and proliferation of
olfactory ensheathing cells from human nose</article-title>. <source>Glia</source>.
<year>2004</year>;<volume>45</volume>(<issue>2</issue>):<fpage>111</fpage>&#x2013;<lpage>123</lpage>.<pub-id pub-id-type="pmid">14730705</pub-id></mixed-citation>
      </ref>
      <ref id="bibr47-0963689718759472">
        <label>47</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Deumens</surname><given-names>R</given-names></name><name><surname>Koopmans</surname><given-names>GC</given-names></name><name><surname>Lemmens</surname><given-names>M</given-names></name><name><surname>M&#xF6;llers</surname><given-names>S</given-names></name><name><surname>Honig</surname><given-names>WM</given-names></name><name><surname>Steinbusch</surname><given-names>HW</given-names></name><name><surname>Brook</surname><given-names>G</given-names></name><name><surname>Joosten</surname><given-names>EA</given-names></name></person-group>
<article-title>Neurite outgrowth promoting effects of enriched and mixed
OEC/ONF cultures</article-title>. <source>Neurosci Lett</source>.
<year>2006</year>;<volume>397</volume>(<issue>1&#x2013;2</issue>):<fpage>20</fpage>&#x2013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">16386847</pub-id></mixed-citation>
      </ref>
      <ref id="bibr48-0963689718759472">
        <label>48</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Toft</surname><given-names>A</given-names></name><name><surname>Tome</surname><given-names>M</given-names></name><name><surname>Barnett</surname><given-names>SC</given-names></name><name><surname>Riddell</surname><given-names>JS</given-names></name></person-group>
<article-title>A comparative study of glial and non-neural cell
properties for transplant-mediated repair of the injured spinal cord</article-title>.
<source>Glia</source>.
<year>2013</year>;<volume>61</volume>(<issue>4</issue>):<fpage>513</fpage>&#x2013;<lpage>528</lpage>.<pub-id pub-id-type="pmid">23322541</pub-id></mixed-citation>
      </ref>
      <ref id="bibr49-0963689718759472">
        <label>49</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Duan</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>B</given-names></name></person-group>
<article-title>Survival and number of olfactory ensheathing cells
transplanted in contused spinal cord of rats</article-title>. <source>Chin J
Traumatol</source>.
<year>2010</year>;<volume>13</volume>(<issue>6</issue>):<fpage>356</fpage>&#x2013;<lpage>361</lpage>.<pub-id pub-id-type="pmid">21126394</pub-id></mixed-citation>
      </ref>
      <ref id="bibr50-0963689718759472">
        <label>50</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Houle</surname><given-names>JD</given-names></name><name><surname>Ye</surname><given-names>JH</given-names></name></person-group>
<article-title>Survival of chronically-injured neurons can be prolonged
by treatment with neurotrophic factors</article-title>. <source>Neuroscience</source>.
<year>1999</year>;<volume>94</volume>(<issue>3</issue>):<fpage>929</fpage>&#x2013;<lpage>936</lpage>.<pub-id pub-id-type="pmid">10579585</pub-id></mixed-citation>
      </ref>
      <ref id="bibr51-0963689718759472">
        <label>51</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ma</surname><given-names>Y-H</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Cao</surname><given-names>L</given-names></name><name><surname>Su</surname><given-names>J-C</given-names></name><name><surname>Wang</surname><given-names>Z-W</given-names></name><name><surname>Xu</surname><given-names>A-B</given-names></name><name><surname>Zhang</surname><given-names>S-C</given-names></name></person-group>
<article-title>Effect of neurotrophin-3 genetically modified olfactory
ensheathing cells transplantation on spinal cord injury</article-title>. <source>Cell
Transplant</source>.
<year>2010</year>;<volume>19</volume>(<issue>2</issue>):<fpage>167</fpage>&#x2013;<lpage>177</lpage>.<pub-id pub-id-type="pmid">20350361</pub-id></mixed-citation>
      </ref>
      <ref id="bibr52-0963689718759472">
        <label>52</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Gutala</surname><given-names>R</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>JZ</given-names></name><name><surname>Sheela</surname><given-names>RCS</given-names></name><name><surname>Ticku</surname><given-names>MK</given-names></name><name><surname>Li</surname><given-names>MD</given-names></name></person-group>
<article-title>Regulation of platelet-derived growth factor signaling
pathway by ethanol, nicotine, or both in mouse cortical neurons</article-title>.
<source>Alcohol Clin Exp Res</source>.
<year>2007</year>;<volume>31</volume>(<issue>3</issue>):<fpage>357</fpage>&#x2013;<lpage>375</lpage>.<pub-id pub-id-type="pmid">17295719</pub-id></mixed-citation>
      </ref>
      <ref id="bibr53-0963689718759472">
        <label>53</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chong</surname><given-names>ZZ</given-names></name><name><surname>Tor</surname><given-names>SB</given-names></name><name><surname>Loh</surname><given-names>NH</given-names></name><name><surname>Wong</surname><given-names>TN</given-names></name><name><surname>Ga&#xF1;&#xE1;n-Calvo</surname><given-names>AM</given-names></name><name><surname>Tan</surname><given-names>SH</given-names></name><name><surname>Nguyen</surname><given-names>N-T</given-names></name></person-group>
<article-title>Acoustofluidic control of bubble size in microfluidic
flow-focusing configuration</article-title>. <source>Lab Chip</source>.
<year>2014</year>;<volume>15</volume>:<fpage>996</fpage>&#x2013;<lpage>999</lpage>.</mixed-citation>
      </ref>
      <ref id="bibr54-0963689718759472">
        <label>54</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cunha</surname><given-names>C</given-names></name><name><surname>Brambilla</surname><given-names>R</given-names></name><name><surname>Thomas</surname><given-names>KL</given-names></name></person-group>
<article-title>A simple role for BDNF in learning and
memory?</article-title>
<source>Front Mol Neurosci</source>.
<year>2010</year>;<volume>3</volume>:<fpage>1</fpage>&#x2013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">20162032</pub-id></mixed-citation>
      </ref>
      <ref id="bibr55-0963689718759472">
        <label>55</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ivanisevic</surname><given-names>L</given-names></name><name><surname>Banerjee</surname><given-names>K</given-names></name><name><surname>Saragovi</surname><given-names>HU</given-names></name></person-group>
<article-title>Differential cross-regulation of TrkA and TrkC tyrosine
kinase receptors with p75</article-title>. <source>Oncogene</source>.
<year>2003</year>;<volume>22</volume>(<issue>36</issue>):<fpage>5677</fpage>&#x2013;<lpage>5685</lpage>.<pub-id pub-id-type="pmid">12944916</pub-id></mixed-citation>
      </ref>
      <ref id="bibr56-0963689718759472">
        <label>56</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Yoon</surname><given-names>SO</given-names></name><name><surname>Casaccia-Bonnefil</surname><given-names>P</given-names></name><name><surname>Carter</surname><given-names>B</given-names></name><name><surname>Chao</surname><given-names>M V</given-names></name></person-group>
<article-title>Competitive signaling between TrkA and p75 nerve growth
factor receptors determines cell survival</article-title>. <source>J. Neurosci</source>.
<year>1998</year>;<volume>18</volume>(<issue>9</issue>):<fpage>3273</fpage>&#x2013;<lpage>3281</lpage>.<pub-id pub-id-type="pmid">9547236</pub-id></mixed-citation>
      </ref>
      <ref id="bibr57-0963689718759472">
        <label>57</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raucci</surname><given-names>F</given-names></name><name><surname>Tiong</surname><given-names>JD</given-names></name><name><surname>Wray</surname><given-names>S</given-names></name></person-group>
<article-title>P75 nerve growth factor receptors modulate development of
GnRH neurons and olfactory ensheathing cells</article-title>. <source>Front
Neurosci</source>.
<year>2013</year>;<volume>7</volume>:<fpage>1</fpage>&#x2013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">23386807</pub-id></mixed-citation>
      </ref>
      <ref id="bibr58-0963689718759472">
        <label>58</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ryd&#xE9;n</surname><given-names>M</given-names></name><name><surname>Hempstead</surname><given-names>B</given-names></name><name><surname>Ib&#xE1;&#xF1;ez</surname><given-names>CF</given-names></name></person-group>
<article-title>Differential modulation of neuron survival during
development by nerve growth factor binding to the p75 neurotrophin
receptor</article-title>. <source>J Biol Chem</source>.
<year>1997</year>;<volume>272</volume>(<issue>26</issue>):<fpage>16322</fpage>&#x2013;<lpage>16328</lpage>.<pub-id pub-id-type="pmid">9195937</pub-id></mixed-citation>
      </ref>
      <ref id="bibr59-0963689718759472">
        <label>59</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dobrowsky</surname><given-names>RT</given-names></name><name><surname>Werner</surname><given-names>MH</given-names></name><name><surname>Castellino</surname><given-names>AM</given-names></name><name><surname>Chao</surname><given-names>MV</given-names></name><name><surname>Hannun</surname><given-names>YA</given-names></name></person-group>
<article-title>Activation of the sphingomyelin cycle through the
low-affinity neurotrophin receptor</article-title>. <source>Science</source>.
<year>1994</year>;<volume>265</volume>(<issue>5178</issue>):<fpage>1596</fpage>&#x2013;<lpage>1599</lpage>.<pub-id pub-id-type="pmid">8079174</pub-id></mixed-citation>
      </ref>
      <ref id="bibr60-0963689718759472">
        <label>60</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Testi</surname><given-names>R</given-names></name></person-group>
<article-title>Sphingomyelin breakdown and cell fate</article-title>.
<source>Trends Biochem Sci</source>.
<year>1996</year>;<volume>21</volume>(<issue>12</issue>):<fpage>468</fpage>&#x2013;<lpage>471</lpage>.<pub-id pub-id-type="pmid">9009829</pub-id></mixed-citation>
      </ref>
      <ref id="bibr61-0963689718759472">
        <label>61</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nazareth</surname><given-names>L</given-names></name><name><surname>Tello Velasquez</surname><given-names>J</given-names></name><name><surname>Lineburg</surname><given-names>KE</given-names></name><name><surname>Chehrehasa</surname><given-names>F</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name><name><surname>Ekberg</surname><given-names>JAK</given-names></name></person-group>
<article-title>Differing phagocytic capacities of accessory and main
olfactory ensheathing cells and the implication for olfactory glia transplantation
therapies</article-title>. <source>Mol Cell Neurosci</source>.
<year>2015</year>;<volume>65</volume>:<fpage>92</fpage>&#x2013;<lpage>101</lpage>.<pub-id pub-id-type="pmid">25752729</pub-id></mixed-citation>
      </ref>
      <ref id="bibr62-0963689718759472">
        <label>62</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tello Velasquez</surname><given-names>J</given-names></name><name><surname>Watts</surname><given-names>ME</given-names></name><name><surname>Todorovic</surname><given-names>M</given-names></name><name><surname>Nazareth</surname><given-names>L</given-names></name><name><surname>Pastrana</surname><given-names>E</given-names></name><name><surname>Diaz-Nido</surname><given-names>J</given-names></name><name><surname>Lim</surname><given-names>F</given-names></name><name><surname>Ekberg</surname><given-names>JAK</given-names></name><name><surname>Quinn</surname><given-names>RJ</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name></person-group>
<article-title>Low-dose curcumin stimulates proliferation, migration and
phagocytic activity of olfactory ensheathing cells</article-title>. <source>PLoS
One</source>.
<year>2014</year>;<volume>9</volume>(<issue>10</issue>):<fpage>1</fpage>&#x2013;<lpage>15</lpage>.</mixed-citation>
      </ref>
      <ref id="bibr63-0963689718759472">
        <label>63</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Friedman</surname><given-names>WJ</given-names></name><name><surname>Greene</surname><given-names>LA</given-names></name></person-group>
<article-title>Neurotrophin signaling via Trks and p75</article-title>.
<source>Exp Cell Res</source>.
<year>1999</year>;<volume>253</volume>(<issue>1</issue>):<fpage>131</fpage>&#x2013;<lpage>142</lpage>.<pub-id pub-id-type="pmid">10579918</pub-id></mixed-citation>
      </ref>
      <ref id="bibr64-0963689718759472">
        <label>64</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Babcock</surname><given-names>AA</given-names></name><name><surname>Kuziel</surname><given-names>WA</given-names></name><name><surname>Rivest</surname><given-names>S</given-names></name><name><surname>Owens</surname><given-names>T</given-names></name></person-group>
<article-title>Chemokine expression by glial cells directs leukocytes to
sites of axonal injury in the CNS</article-title>. <source>J Neurosci</source>.
<year>2003</year>;<volume>23</volume>(<issue>21</issue>):<fpage>7922</fpage>&#x2013;<lpage>7930</lpage>.<pub-id pub-id-type="pmid">12944523</pub-id></mixed-citation>
      </ref>
      <ref id="bibr65-0963689718759472">
        <label>65</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bleul</surname><given-names>CC</given-names></name><name><surname>Fuhlbrigge</surname><given-names>RC</given-names></name><name><surname>Casasnovas</surname><given-names>JM</given-names></name><name><surname>Aiuti</surname><given-names>A</given-names></name><name><surname>Springer</surname><given-names>TA</given-names></name></person-group>
<article-title>A highly efficacious lymphocyte chemoattractant, stromal
cell-derived factor 1 (SDF-1)</article-title>. <source>J Exp Med</source>.
<year>1996</year>;<volume>184</volume>(<issue>3</issue>):<fpage>1101</fpage>&#x2013;<lpage>1109</lpage>.<pub-id pub-id-type="pmid">9064327</pub-id></mixed-citation>
      </ref>
      <ref id="bibr66-0963689718759472">
        <label>66</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>McKimmie</surname><given-names>CS</given-names></name><name><surname>Graham</surname><given-names>GJ</given-names></name></person-group>
<article-title>Astrocytes modulate the chemokine network in a
pathogen-specific manner</article-title>. <source>Biochem Biophys Res Commun</source>.
<year>2010</year>;<volume>394</volume>(<issue>4</issue>):<fpage>1006</fpage>&#x2013;<lpage>1011</lpage>.<pub-id pub-id-type="pmid">20331977</pub-id></mixed-citation>
      </ref>
      <ref id="bibr67-0963689718759472">
        <label>67</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Asan</surname><given-names>E</given-names></name><name><surname>Langenhan</surname><given-names>T</given-names></name><name><surname>Holtmann</surname><given-names>B</given-names></name><name><surname>Bock</surname><given-names>H</given-names></name><name><surname>Sendtner</surname><given-names>M</given-names></name><name><surname>Carroll</surname><given-names>P</given-names></name></person-group>
<article-title>Ciliary neurotrophic factor in the olfactory bulb of rats
and mice</article-title>. <source>Neuroscience</source>.
<year>2003</year>;<volume>120</volume>(<issue>1</issue>):<fpage>99</fpage>&#x2013;<lpage>112</lpage>.<pub-id pub-id-type="pmid">12849744</pub-id></mixed-citation>
      </ref>
      <ref id="bibr68-0963689718759472">
        <label>68</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wewetzer</surname><given-names>K</given-names></name><name><surname>Grothe</surname><given-names>C</given-names></name><name><surname>Claus</surname><given-names>P</given-names></name></person-group>
<article-title>In vitro expression and regulation of ciliary neurotrophic
factor and its alpha receptor subunit in neonatal rat olfactory ensheathing
cells</article-title>. <source>Neurosci Lett</source>.
<year>2001</year>;<volume>306</volume>(<issue>3</issue>):<fpage>165</fpage>&#x2013;<lpage>168</lpage>.<pub-id pub-id-type="pmid">11406321</pub-id></mixed-citation>
      </ref>
      <ref id="bibr69-0963689718759472">
        <label>69</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lakatos</surname><given-names>A</given-names></name><name><surname>Franklin</surname><given-names>RJM</given-names></name><name><surname>Barnett</surname><given-names>SC</given-names></name></person-group>
<article-title>Olfactory ensheathing cells and Schwann cells differ in
their in vitro interactions with astrocytes</article-title>. <source>Glia</source>.
<year>2000</year>;<volume>32</volume>(<issue>3</issue>):<fpage>214</fpage>&#x2013;<lpage>225</lpage>.<pub-id pub-id-type="pmid">11102963</pub-id></mixed-citation>
      </ref>
      <ref id="bibr70-0963689718759472">
        <label>70</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O&#x2019;Toole</surname><given-names>DA</given-names></name><name><surname>West a</surname><given-names>K</given-names></name><name><surname>Chuah</surname><given-names>MI</given-names></name></person-group>
<article-title>Effect of olfactory ensheathing cells on reactive
astrocytes in vitro</article-title>. <source>Cell Mol Life Sci</source>.
<year>2007</year>;<volume>64</volume>(<issue>10</issue>):<fpage>1303</fpage>&#x2013;<lpage>1309</lpage>.<pub-id pub-id-type="pmid">17447004</pub-id></mixed-citation>
      </ref>
      <ref id="bibr71-0963689718759472">
        <label>71</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>L&#xF3;pez-Vales</surname><given-names>R</given-names></name><name><surname>Garc&#xED;a-Al&#xED;as</surname><given-names>G</given-names></name><name><surname>For&#xE9;s</surname><given-names>J</given-names></name><name><surname>Vela</surname><given-names>JM</given-names></name><name><surname>Navarro</surname><given-names>X</given-names></name><name><surname>Verd&#xFA;</surname><given-names>E</given-names></name></person-group>
<article-title>Transplanted olfactory ensheathing cells modulate the
inflammatory response in the injured spinal cord</article-title>. <source>Neuron Glia
Biol</source>.
<year>2004</year>;<volume>1</volume>(<issue>3</issue>):<fpage>201</fpage>&#x2013;<lpage>209</lpage>.<pub-id pub-id-type="pmid">18634597</pub-id></mixed-citation>
      </ref>
      <ref id="bibr72-0963689718759472">
        <label>72</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hale</surname><given-names>DM</given-names></name><name><surname>Ray</surname><given-names>S</given-names></name><name><surname>Leung</surname><given-names>JY</given-names></name><name><surname>Holloway</surname><given-names>AF</given-names></name><name><surname>Chung</surname><given-names>RS</given-names></name><name><surname>West</surname><given-names>AK</given-names></name><name><surname>Chuah</surname><given-names>MI</given-names></name></person-group>
<article-title>Olfactory ensheathing cells moderate nuclear factor kappaB
translocation in astrocytes</article-title>. <source>Mol Cell Neurosci</source>.
<year>2011</year>;<volume>46</volume>(<issue>1</issue>):<fpage>213</fpage>&#x2013;<lpage>221</lpage>.<pub-id pub-id-type="pmid">20840869</pub-id></mixed-citation>
      </ref>
      <ref id="bibr73-0963689718759472">
        <label>73</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Windus</surname><given-names>LCE</given-names></name><name><surname>Chehrehasa</surname><given-names>F</given-names></name><name><surname>Lineburg</surname><given-names>KE</given-names></name><name><surname>Claxton</surname><given-names>C</given-names></name><name><surname>MacKay-Sim</surname><given-names>A</given-names></name><name><surname>Key</surname><given-names>B</given-names></name><name><surname>St John</surname><given-names>JA</given-names></name></person-group>
<article-title>Stimulation of olfactory ensheathing cell motility
enhances olfactory axon growth</article-title>. <source>Cell Mol Life Sci</source>.
<year>2011</year>;<volume>68</volume>(<issue>19</issue>):<fpage>3233</fpage>&#x2013;<lpage>3247</lpage>.<pub-id pub-id-type="pmid">21318262</pub-id></mixed-citation>
      </ref>
      <ref id="bibr74-0963689718759472">
        <label>74</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Boruch</surname><given-names>A V.</given-names></name><name><surname>Conners</surname><given-names>JJ</given-names></name><name><surname>Pipitone</surname><given-names>M</given-names></name><name><surname>Deadwyler</surname><given-names>G</given-names></name><name><surname>Storer</surname><given-names>PD</given-names></name><name><surname>Devries</surname><given-names>GH</given-names></name><name><surname>Jones</surname><given-names>KJ</given-names></name></person-group>
<article-title>Neurotrophic and migratory properties of an olfactory
ensheathing cell line</article-title>. <source>Glia</source>.
<year>2001</year>;<volume>33</volume>(<issue>3</issue>):<fpage>225</fpage>&#x2013;<lpage>229</lpage>.<pub-id pub-id-type="pmid">11241740</pub-id></mixed-citation>
      </ref>
      <ref id="bibr75-0963689718759472">
        <label>75</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Niederhauser</surname><given-names>O</given-names></name><name><surname>Mangold</surname><given-names>M</given-names></name><name><surname>Schubenel</surname><given-names>R</given-names></name><name><surname>Kusznir</surname><given-names>EA</given-names></name><name><surname>Schmidt</surname><given-names>D</given-names></name><name><surname>Hertel</surname><given-names>C</given-names></name></person-group>
<article-title>NGF ligand alters NGF signaling via p75(NTR) and
TrkA</article-title>. <source>J Neurosci Res</source>.
<year>2000</year>;<volume>61</volume>(<issue>3</issue>):<fpage>263</fpage>&#x2013;<lpage>272</lpage>.<pub-id pub-id-type="pmid">10900073</pub-id></mixed-citation>
      </ref>
      <ref id="bibr76-0963689718759472">
        <label>76</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lang</surname><given-names>B-C</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Lv</surname><given-names>L-Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>T-Y</given-names></name><name><surname>Yang</surname><given-names>L-H</given-names></name><name><surname>Liao</surname><given-names>D-Q</given-names></name><name><surname>Zhang</surname><given-names>W-S</given-names></name><name><surname>Wang</surname><given-names>T-H</given-names></name></person-group>
<article-title>OECs transplantation results in neuropathic pain
associated with BDNF regulating ERK activity in rats following cord
hemisection</article-title>. <source>BMC Neurosci</source>.
<year>2013</year>;<volume>14</volume>(<issue>1</issue>):<fpage>80</fpage>.<pub-id pub-id-type="pmid">23914898</pub-id></mixed-citation>
      </ref>
      <ref id="bibr77-0963689718759472">
        <label>77</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Cong</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>MM</given-names></name><name><surname>Luo</surname><given-names>N</given-names></name><name><surname>Kuang</surname><given-names>F</given-names></name><name><surname>You</surname><given-names>SW</given-names></name></person-group>
<article-title>Neutralization of BDNF attenuates the in vitro protective
effects of olfactory ensheathing cell-conditioned medium on scratch-insulted retinal
ganglion cells</article-title>. <source>Cell Mol Neurobiol</source>.
<year>2011</year>;<volume>31</volume>(<issue>3</issue>):<fpage>357</fpage>&#x2013;<lpage>364</lpage>.<pub-id pub-id-type="pmid">21082236</pub-id></mixed-citation>
      </ref>
      <ref id="bibr78-0963689718759472">
        <label>78</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Guo</surname><given-names>L</given-names></name><name><surname>Moon</surname><given-names>C</given-names></name><name><surname>Niehaus</surname><given-names>K</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Ratner</surname><given-names>N</given-names></name></person-group>
<article-title>Rac1 controls Schwann cell myelination through cAMP and
NF2/merlin</article-title>. <source>J Neurosci</source>.
<year>2012</year>;<volume>32</volume>(<issue>48</issue>):<fpage>17251</fpage>&#x2013;<lpage>17261</lpage>.<pub-id pub-id-type="pmid">23197717</pub-id></mixed-citation>
      </ref>
      <ref id="bibr79-0963689718759472">
        <label>79</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Nodari</surname><given-names>A</given-names></name><name><surname>Zambroni</surname><given-names>D</given-names></name><name><surname>Quattrini</surname><given-names>A</given-names></name><name><surname>Court</surname><given-names>FA</given-names></name><name><surname>D&#x2019;Urso</surname><given-names>A</given-names></name><name><surname>Recchia</surname><given-names>A</given-names></name><name><surname>Tybulewicz</surname><given-names>VLJ</given-names></name><name><surname>Wrabetz</surname><given-names>L</given-names></name></person-group>, <article-title>Feltri ML. &#x3B2;1 integrin activates Rac1 in Schwann cells to
generate radial lamellae during axonal sorting and myelination</article-title>.
<source>J Cell Biol</source>.
<year>2007</year>;<volume>177</volume>(<issue>6</issue>):<fpage>1063</fpage>&#x2013;<lpage>1075</lpage>.<pub-id pub-id-type="pmid">17576799</pub-id></mixed-citation>
      </ref>
      <ref id="bibr80-0963689718759472">
        <label>80</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>OAR</given-names></name><name><surname>Gordon</surname><given-names>T</given-names></name></person-group>
<article-title>Transforming growth factor-beta and forskolin attenuate
the adverse effects of long-term Schwann cell denervation on peripheral nerve
regeneration in vivo</article-title>. <source>Glia</source>.
<year>2002</year>;<volume>37</volume>(<issue>3</issue>):<fpage>206</fpage>&#x2013;<lpage>218</lpage>.<pub-id pub-id-type="pmid">11857679</pub-id></mixed-citation>
      </ref>
      <ref id="bibr81-0963689718759472">
        <label>81</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schnell</surname><given-names>L</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Kolbeck</surname><given-names>R</given-names></name><name><surname>Barde</surname><given-names>YA</given-names></name><name><surname>Schwab</surname><given-names>ME</given-names></name></person-group>
<article-title>Neurotrophin-3 enhances sprouting of corticospinal tract
during development and after adult spinal cord lesion</article-title>.
<source>Nature</source>.
<year>1994</year>;<volume>367</volume>(<issue>6459</issue>):<fpage>170</fpage>&#x2013;<lpage>173</lpage>.<pub-id pub-id-type="pmid">8114912</pub-id></mixed-citation>
      </ref>
      <ref id="bibr82-0963689718759472">
        <label>82</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Taylor</surname><given-names>V</given-names></name><name><surname>Zgraggen</surname><given-names>C</given-names></name><name><surname>Naef</surname><given-names>R</given-names></name><name><surname>Suter</surname><given-names>U</given-names></name></person-group>
<article-title>Fibroblast growth factors (FGF-1, FGF-2) promote migration
and neurite growth of mouse cochlear ganglion cells in vitro: Immunohistochemistry and
antibody perturbation</article-title>. <source>J Neurosci Res</source>.
<year>2000</year>;<volume>62</volume>(<issue>1</issue>):<fpage>40</fpage>&#x2013;<lpage>55</lpage>.<pub-id pub-id-type="pmid">11002286</pub-id></mixed-citation>
      </ref>
      <ref id="bibr83-0963689718759472">
        <label>83</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stachowiak</surname><given-names>MK</given-names></name><name><surname>Maher</surname><given-names>PA</given-names></name><name><surname>Stachowiak</surname><given-names>EK</given-names></name></person-group>
<article-title>Integrative nuclear signaling in cell development&#x2014;a role
for FGF receptor-1</article-title>. <source>DNA Cell Biol</source>.
<year>2007</year>;<volume>26</volume>(<issue>12</issue>):<fpage>811</fpage>&#x2013;<lpage>826</lpage>.<pub-id pub-id-type="pmid">18021009</pub-id></mixed-citation>
      </ref>
      <ref id="bibr84-0963689718759472">
        <label>84</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hsu</surname><given-names>P</given-names></name></person-group>
<article-title>Basic fibroblast growth factor and fibroblast growth
factor receptors in adult olfactory epithelium</article-title>. <source>Brain
Res</source>.
<year>2001</year>;<volume>896</volume>(<issue>1&#x2013;2</issue>):<fpage>188</fpage>&#x2013;<lpage>197</lpage>.<pub-id pub-id-type="pmid">11277992</pub-id></mixed-citation>
      </ref>
      <ref id="bibr85-0963689718759472">
        <label>85</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schlessinger</surname><given-names>J</given-names></name><name><surname>Plotnikov</surname><given-names>AN</given-names></name><name><surname>Ibrahimi</surname><given-names>OA</given-names></name><name><surname>Eliseenkova</surname><given-names>AV.</given-names></name><name><surname>Yeh</surname><given-names>BK</given-names></name><name><surname>Yayon</surname><given-names>A</given-names></name><name><surname>Linhardt</surname><given-names>RJ</given-names></name><name><surname>Mohammadi</surname><given-names>M</given-names></name></person-group>
<article-title>Crystal structure of a ternary FGF-FGFR-heparin complex
reveals a dual role for heparin in FGFR binding and dimerization</article-title>.
<source>Mol Cell</source>.
<year>2000</year>;<volume>6</volume>(<issue>3</issue>):<fpage>743</fpage>&#x2013;<lpage>750</lpage>.<pub-id pub-id-type="pmid">11030354</pub-id></mixed-citation>
      </ref>
      <ref id="bibr86-0963689718759472">
        <label>86</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reiland</surname><given-names>J</given-names></name><name><surname>Kempf</surname><given-names>D</given-names></name><name><surname>Roy</surname><given-names>M</given-names></name><name><surname>Denkins</surname><given-names>Y</given-names></name><name><surname>Marchetti</surname><given-names>D</given-names></name></person-group>
<article-title>FGF2 binding, signaling, and angiogenesis are modulated by
heparanase in metastatic melanoma cells</article-title>. <source>Neoplasia</source>.
<year>2006</year>;<volume>8</volume>(<issue>7</issue>):<fpage>596</fpage>&#x2013;<lpage>606</lpage>.<pub-id pub-id-type="pmid">16867222</pub-id></mixed-citation>
      </ref>
      <ref id="bibr87-0963689718759472">
        <label>87</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Knapp</surname><given-names>PE</given-names></name><name><surname>Adams</surname><given-names>MH</given-names></name></person-group>
<article-title>Epidermal growth factor promotes oligodendrocyte process
formation and regrowth after injury</article-title>. <source>Exp Cell Res</source>.
<year>2004</year>;<volume>296</volume>(<issue>2</issue>):<fpage>135</fpage>&#x2013;<lpage>144</lpage>.<pub-id pub-id-type="pmid">15149844</pub-id></mixed-citation>
      </ref>
      <ref id="bibr88-0963689718759472">
        <label>88</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sheng</surname><given-names>HZ</given-names></name><name><surname>Turnley</surname><given-names>A</given-names></name><name><surname>Murphy</surname><given-names>M</given-names></name><name><surname>Bernard</surname><given-names>CC</given-names></name><name><surname>Bartlett</surname><given-names>PF</given-names></name></person-group>
<article-title>Epidermal growth factor inhibits the expression of myelin
basic protein in oligodendrocytes</article-title>. <source>J Neurosci Res</source>.
<year>1989</year>;<volume>23</volume>(<issue>4</issue>):<fpage>425</fpage>&#x2013;<lpage>432</lpage>.<pub-id pub-id-type="pmid">2475642</pub-id></mixed-citation>
      </ref>
      <ref id="bibr89-0963689718759472">
        <label>89</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Richter</surname><given-names>MW</given-names></name><name><surname>Fletcher</surname><given-names>PA</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Tetzlaff</surname><given-names>W</given-names></name><name><surname>Roskams</surname><given-names>AJ</given-names></name></person-group>
<article-title>Lamina propria and olfactory bulb ensheathing cells
exhibit differential integration and migration and promote differential axon sprouting
in the lesioned spinal cord</article-title>. <source>J Neurosci</source>.
<year>2005</year>;<volume>25</volume>(<issue>46</issue>):<fpage>10700</fpage>&#x2013;<lpage>11</lpage>.<pub-id pub-id-type="pmid">16291943</pub-id></mixed-citation>
      </ref>
      <ref id="bibr90-0963689718759472">
        <label>90</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Emanueli</surname><given-names>C</given-names></name><name><surname>Salis</surname><given-names>MB</given-names></name><name><surname>Pinna</surname><given-names>A</given-names></name><name><surname>Graiani</surname><given-names>G</given-names></name><name><surname>Manni</surname><given-names>L</given-names></name><name><surname>Madeddu</surname><given-names>P</given-names></name></person-group>
<article-title>Nerve growth factor promotes angiogenesis and
arteriogenesis in ischemic hindlimbs</article-title>. <source>Circulation</source>.
<year>2002</year>;<volume>106</volume>(<issue>17</issue>):<fpage>2257</fpage>&#x2013;<lpage>2262</lpage>.<pub-id pub-id-type="pmid">12390957</pub-id></mixed-citation>
      </ref>
      <ref id="bibr91-0963689718759472">
        <label>91</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kubota</surname><given-names>Y</given-names></name><name><surname>Suda</surname><given-names>T</given-names></name></person-group>
<article-title>Feedback mechanism between blood vessels and astrocytes in
retinal vascular development</article-title>. <source>Trends Cardiovasc Med</source>.
<year>2009</year>;<volume>19</volume>(<issue>2</issue>):<fpage>38</fpage>&#x2013;<lpage>43</lpage>.<pub-id pub-id-type="pmid">19577710</pub-id></mixed-citation>
      </ref>
      <ref id="bibr92-0963689718759472">
        <label>92</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liem</surname><given-names>RKH</given-names></name><name><surname>Messing</surname><given-names>A</given-names></name></person-group>
<article-title>Dysfunctions of neuronal and glial intermediate filaments
in disease</article-title>. <source>J Clin Invest</source>.
<year>2009</year>;<volume>119</volume>(<issue>7</issue>):<fpage>1814</fpage>&#x2013;<lpage>1824</lpage>.<pub-id pub-id-type="pmid">19587456</pub-id></mixed-citation>
      </ref>
      <ref id="bibr93-0963689718759472">
        <label>93</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Weidemann</surname><given-names>A</given-names></name><name><surname>Krohne</surname><given-names>TU</given-names></name><name><surname>Aguilar</surname><given-names>E</given-names></name><name><surname>Kurihara</surname><given-names>T</given-names></name><name><surname>Takeda</surname><given-names>N</given-names></name><name><surname>Dorrell</surname><given-names>MI</given-names></name><name><surname>Simon</surname><given-names>MC</given-names></name><name><surname>Haase</surname><given-names>VH</given-names></name><name><surname>Friedlander</surname><given-names>M</given-names></name><name><surname>Johnson</surname><given-names>RS</given-names></name></person-group>
<article-title>Astrocyte hypoxic response is essential for pathological
but not developmental angiogenesis of the retina</article-title>. <source>Glia</source>.
<year>2010</year>;<volume>58</volume>(<issue>10</issue>):<fpage>1177</fpage>&#x2013;<lpage>1185</lpage>.<pub-id pub-id-type="pmid">20544853</pub-id></mixed-citation>
      </ref>
      <ref id="bibr94-0963689718759472">
        <label>94</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Schollmanns</surname><given-names>C</given-names></name><name><surname>Grugels</surname><given-names>R</given-names></name><name><surname>Tatjej</surname><given-names>D</given-names></name><name><surname>Hoppej</surname><given-names>J</given-names></name><name><surname>Folkmanq</surname><given-names>J</given-names></name><name><surname>Marme</surname><given-names>D</given-names></name><name><surname>Ii</surname><given-names>HAW</given-names></name></person-group>
<article-title>Basic fibroblast growth factor modulates the mitogenic
potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation
of the PDGF alpha receptor in vascular smooth muscle cells</article-title>.
<source>Biochemistry</source>.
<year>1992</year>;<volume>267</volume>(<issue>25</issue>):<fpage>18032</fpage>&#x2013;<lpage>18039</lpage>.</mixed-citation>
      </ref>
      <ref id="bibr95-0963689718759472">
        <label>95</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calof</surname><given-names>AL</given-names></name><name><surname>Lander</surname><given-names>AD</given-names></name></person-group>
<article-title>Relationship between neuronal migration and
cell-substratum adhesion: laminin and merosin promote olfactory neuronal migration but
are anti-adhesive</article-title>. <source>J Cell Biol</source>.
<year>1991</year>;<volume>115</volume>(<issue>3
I</issue>):<fpage>779</fpage>&#x2013;<lpage>794</lpage>.<pub-id pub-id-type="pmid">1918163</pub-id></mixed-citation>
      </ref>
      <ref id="bibr96-0963689718759472">
        <label>96</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaihola</surname><given-names>H</given-names></name><name><surname>Olivier</surname><given-names>J</given-names></name><name><surname>Poromaa</surname><given-names>IS</given-names></name><name><surname>&#xC5;kerud</surname><given-names>H</given-names></name></person-group>
<article-title>The effect of antenatal depression and selective serotonin
reuptake inhibitor treatment on nerve growth factor signaling in human
placenta</article-title>. <source>PLoS One</source>.
<year>2015</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1</fpage>&#x2013;<lpage>15</lpage>.</mixed-citation>
      </ref>
      <ref id="bibr97-0963689718759472">
        <label>97</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reuss</surname><given-names>B</given-names></name><name><surname>Von Bohlen Und Halbach</surname><given-names>O</given-names></name></person-group>
<article-title>Fibroblast growth factors and their receptors in the
central nervous system</article-title>. <source>Cell Tissue Res</source>.
<year>2003</year>;<volume>313</volume>(<issue>2</issue>):<fpage>139</fpage>&#x2013;<lpage>157</lpage>.<pub-id pub-id-type="pmid">12845521</pub-id></mixed-citation>
      </ref>
      <ref id="bibr98-0963689718759472">
        <label>98</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Postigo</surname><given-names>A</given-names></name><name><surname>Calella</surname><given-names>AM</given-names></name><name><surname>Fritzsch</surname><given-names>B</given-names></name><name><surname>Knipper</surname><given-names>M</given-names></name><name><surname>Katz</surname><given-names>D</given-names></name><name><surname>Eilers</surname><given-names>A</given-names></name><name><surname>Schimmang</surname><given-names>T</given-names></name><name><surname>Lewin</surname><given-names>GR</given-names></name><name><surname>Klein</surname><given-names>R</given-names></name><name><surname>Minichiello</surname><given-names>L</given-names></name></person-group>
<article-title>Distinct requirements for TrkB and TrkC signaling in
target innervation by sensory neurons</article-title>. <source>Genes Dev</source>.
<year>2002</year>;<volume>16</volume>(<issue>5</issue>):<fpage>633</fpage>&#x2013;<lpage>645</lpage>.<pub-id pub-id-type="pmid">11877382</pub-id></mixed-citation>
      </ref>
      <ref id="bibr99-0963689718759472">
        <label>99</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dietrich</surname><given-names>WD</given-names></name><name><surname>Levi</surname><given-names>AD</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Green</surname><given-names>BA</given-names></name></person-group>
<article-title>Hypothermic treatment for acute spinal cord
injury</article-title>. <source>Neurotherapeutics</source>.
<year>2011</year>;<volume>8</volume>(<issue>2</issue>):<fpage>229</fpage>&#x2013;<lpage>239</lpage>.<pub-id pub-id-type="pmid">21416406</pub-id></mixed-citation>
      </ref>
      <ref id="bibr100-0963689718759472">
        <label>100</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sakata</surname><given-names>M</given-names></name><name><surname>Yanamoto</surname><given-names>H</given-names></name><name><surname>Hashimoto</surname><given-names>N</given-names></name><name><surname>Iihara</surname><given-names>K</given-names></name><name><surname>Tsukahara</surname><given-names>T</given-names></name><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Kikuchi</surname><given-names>H</given-names></name></person-group>
<article-title>Induction of infarct tolerance by platelet-derived growth
factor against reversible focal ischemia</article-title>. <source>Brain Res</source>.
<year>1998</year>;<volume>784</volume>(<issue>1&#x2013;2</issue>):<fpage>250</fpage>&#x2013;<lpage>255</lpage>.<pub-id pub-id-type="pmid">9518639</pub-id></mixed-citation>
      </ref>
      <ref id="bibr101-0963689718759472">
        <label>101</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chehrehasa</surname><given-names>F</given-names></name><name><surname>Cobcroft</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>YW</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>Goss</surname><given-names>B</given-names></name></person-group>
<article-title>An acute growth factor treatment that preserves function
after spinal cord contusion injury</article-title>. <source>J Neurotrauma</source>.
<year>2014</year>;<volume>31</volume>(<issue>21</issue>):<fpage>1807</fpage>&#x2013;<lpage>1813</lpage>.<pub-id pub-id-type="pmid">24836764</pub-id></mixed-citation>
      </ref>
      <ref id="bibr102-0963689718759472">
        <label>102</label>
        <mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lutton</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>YW</given-names></name><name><surname>Williams</surname><given-names>R</given-names></name><name><surname>Meedeniya</surname><given-names>ACB</given-names></name><name><surname>Mackay-Sim</surname><given-names>A</given-names></name><name><surname>Goss</surname><given-names>B</given-names></name></person-group>
<article-title>Combined VEGF and PDGF treatment reduces secondary
degeneration after spinal cord injury</article-title>. <source>J Neurotrauma</source>.
<year>2012</year>;<volume>29</volume>(<issue>5</issue>):<fpage>957</fpage>&#x2013;<lpage>970</lpage>.<pub-id pub-id-type="pmid">21568693</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>